Other Long-term Liabilities
| | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | June 28, 2026 | | June 29, 2025 |
| Long-term lease liabilities | $99.2 | | | $139.5 | |
Long-term RF supply agreement liabilities(1) | 47.0 | | | 44.5 | |
| | | |
| Long-term customer deposits | 4.3 | | | 15.6 | |
| Other | 3.2 | | | 3.5 | |
| Other long-term liabilities | $153.7 | | | $203.1 | |
(1): Refer to Note 5, "Discontinued Operations," to the consolidated financial statements included herein for additional information. |
|
Contingent Liabilities
The Company recognizes contingent liabilities when it is probable that an asset has been impaired or a liability has been incurred at the date of the financial statements and the amount of the loss can be reasonably estimated. Disclosure in the notes to the financial statements is required for loss contingencies that do not meet both these conditions if there is a reasonable possibility that a loss may have been incurred. See Note 16, “Commitments and Contingencies,” for a discussion of loss contingencies in connection with pending and threatened litigation. The costs of defending legal claims against the Company are expensed as incurred.
Revenue Recognition
Revenue is recognized when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. Substantially all of the Company's revenue is derived from product sales. Revenue is recognized at a point in time based on the Company’s evaluation of when the customer obtains control of the products, and all performance obligations under the terms of the contract are satisfied. Sales of products typically do not include more than one performance obligation.
A portion of the Company’s products are sold through distributors. Distributors stock inventory and sell the Company’s products to their own customer base, which may include: value added resellers; manufacturers who incorporate the Company’s products into their own manufactured goods; or ultimate end users of the Company’s products. The Company recognizes revenue in accordance with the agreed upon terms.
Master supply or distributor agreements are in place with some of the Company's customers and contain terms and conditions including, but not limited to, payment, delivery, incentives and warranty. These agreements sometimes require minimum purchase commitments and/or involve potential penalties to the Company if a defined supply schedule is not met. If a master supply, distributor or other similar agreement is not in place with a customer, the Company considers a purchase order, which is governed by the Company’s standard terms and conditions, to be the contract governing the relationship with that customer.
Pricing terms are negotiated independently on a stand-alone basis. Revenue is measured based on the amount of net consideration to which the Company expects to be entitled to receive in exchange for products or services. Variable consideration is recognized as a reduction of net revenue with a corresponding reserve at the time of revenue recognition, and consists primarily of sales incentives, volume discounts, price concessions and return allowances. Variable consideration is estimated based on contractual terms, historical analysis of customer purchase volumes, or historical analysis using specific data for the type of consideration being assessed.
Some of the Company’s distributors are provided limited rights that allow them to return a portion of inventory (product exchange rights or stock rotation rights) and receive credits for changes in selling prices (price protection rights) or customer pricing arrangements under the Company’s “ship and debit” program or other targeted sales incentives. These estimates are calculated based upon historical experience, product shipment analysis, current economic conditions, on-hand inventory at the distributor, and customer contractual arrangements. The Company believes that it can reasonably and reliably estimate the allowance for distributor credits at the time of sale. Accordingly, estimates for these rights are recognized at the time of sale as a distributor reserve and a reduction of product revenue.
Under the ship and debit program, products are sold to distributors at negotiated prices and the distributors are required to pay for the products purchased within the Company’s standard commercial terms. Subsequent to the initial product purchase, a distributor may request a price allowance for a particular part number(s) for certain target customers, prior to the distributor reselling the particular part to that customer. If the Company approves an allowance and the distributor resells the product to the target customer, the Company credits the distributor according to the allowance the Company approved. These credits are applied against the reserve that the Company establishes upon initial shipment of product to the distributor.
Leases
At lease inception, the Company determines an arrangement is a lease if the contract involves the use of a distinct identified asset, the lessor does not have substantive substitution rights, and the lessee obtains control of the asset throughout the period by obtaining substantially all of the economic benefit of the asset and the right to direct the use of the asset. Depending on the terms, leases are classified as either operating or finance leases, if the Company is the lessee. The Company does not have any sales-type or direct financing leases. Lease agreements frequently include other services such as maintenance, electricity, security, janitorial and reception services. The Company accounts for the lease and non-lease components in its arrangements as a single lease component.
Accounting for Leases as a Lessee
Right-of-use ("ROU") assets represent the Company's right to use an underlying asset during the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Assets and liabilities are recognized based on the present value of lease payments over the lease term. Most leases include one or more options to renew, with renewal terms that can extend the lease term from one to five years or more. The exercise of the renewal option is at the Company's sole discretion and the Company considers these options in determining the lease term used to establish its ROU assets and lease liabilities. The Company remeasures its lease liability and adjusts the related ROU asset upon the occurrence of the following: lease modifications not accounted for as a separate contract; a triggering event that changes the certainty of the lessee exercising an option to renew or terminate the lease, or purchase the underlying asset; a change to the amount probable of being owed by the Company under a residual value guarantee; or the resolution of a contingency upon which the variable lease payments are based such that those payments become fixed.
Because most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. Operating lease expense is generally recognized on a straight-line basis over the lease term. Finance lease assets are generally amortized over the term of the lease. If the finance lease transfers ownership of the underlying asset to the Company, or the Company is reasonably certain it will exercise an option to purchase the underlying asset, the finance lease assets are amortized on a straight-line basis over the useful life of the asset. Interest expense on the finance lease liability is recognized using the effective interest rate method and is presented within interest expense on the Company’s consolidated statements of operations.
Operating leases with a lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases in lease payments based on changes in index rates, are not included in the ROU assets or liabilities. These variable lease payments are expensed as incurred.
Gain on Sale of Disposal of Property
During the period from June 30, 2025 to September 29, 2025 the Company recognized a gain of $5.7 million primarily from sales to customers of certain equipment that the Company no longer intended to use. During the period from September 30, 2025 to June 28, 2026, the Company recognized a gain of $5.4 million, related to the sale of one building, which included the building improvements and land of a 254,000 square foot idle property located in Durham, North Carolina and sales to customers of certain equipment that the Company no longer intended to use.
During fiscal 2025, the Company recognized a gain of $20.0 million primarily from the sale of two properties including buildings, building improvements and land of a 283,000 square foot idle property located in Farmers Branch, Texas and the Company's 179,000 square foot property located in Research Triangle Park, North Carolina. Please refer to Note 5, "Discontinued Operations" for more information regarding the sale of the RTP Fab (as defined below).
Restructuring and Other Expenses
The following table summarizes the components of Restructuring and other operating expenses:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended | | Fiscal Year Ended |
| (in millions of U.S. Dollars) | | | June 29, 2025 | | June 30, 2024 |
| Pre-petition charges | $— | | | $— | | | $55.8 | | | $— | |
| Impairment losses on abandoned assets | 2.6 | | | 0.1 | | | 176.5 | | | 1.2 | |
| Legal settlements | — | | | — | | | 17.0 | | | — | |
| | | | | | | |
| Restructuring and other exit costs | 15.0 | | | 3.6 | | | 134.9 | | | — | |
| Project, transformation and transaction costs | 25.2 | | | 13.8 | | | 29.5 | | | 18.3 | |
| Amortization of fresh start accounting and acquisition-related intangibles | 11.9 | | | — | | | 1.1 | | | 1.1 | |
| Executive severance costs | — | | | — | | | 1.4 | | | — | |
| Other | — | | | 2.9 | | | 1.4 | | | — | |
| Restructuring and other expenses | $54.7 | | | $20.4 | | | $417.6 | | | $20.6 | |
Pre-Petition Charges
Pre-petition charges recognized during fiscal 2025 consist primarily of professional fees related to, but incurred prior to, the filing of the Chapter 11 Cases.
Non-Operating Income, net
The following table summarizes the components of non-operating income, net:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended | | Fiscal Year Ended |
| (in millions of U.S. Dollars) | | | June 29, 2025 | | June 30, 2024 |
| Changes in fair value of liability classified derivative contracts | ($87.8) | | | $— | | | $— | | | $— | |
| Gain on RTP Fab Transfer | — | | | (25.4) | | | — | | | — | |
| Gain on contingent cash | (10.0) | | | — | | | — | | | — | |
| Interest income | (30.3) | | | (8.9) | | | (67.6) | | | (135.0) | |
| Loss on debt extinguishment | 3.3 | | | — | | | — | | | — | |
| Realized loss (gain) on equity investment | — | | | 10.9 | | | (22.6) | | | (18.5) | |
Loss on customs matter(1) | — | | | — | | | — | | | 7.7 | |
| Loss on Wafer Supply Agreement | — | | | — | | | 9.2 | | | 25.3 | |
| Write-off of deferred financing costs | — | | | — | | | 54.7 | | | — | |
| Other expense, net | 1.3 | | | 1.0 | | | 0.8 | | | 1.4 | |
| Non-operating income, net | ($123.5) | | | ($22.4) | | | ($25.5) | | | ($119.1) | |
(1) In fiscal 2024, the Company recognized customs duties totaling approximately $7.7 million for alleged undervaluation of duties related to transactions by the Company's former Lighting Products business unit from 2012 to 2017.
Advertising
The Company expenses the costs of producing advertisements at the time production occurs and expenses the cost of communicating the advertising in the period in which the advertising is used. Advertising costs are included in sales, general and administrative expenses in the consolidated statements of operations and amounted to approximately $3.8 million, $2.4 million, $11.6 million, and $13.8 million for the period from June 30, 2025 to September 29, 2025 and the period from September 30, 2025 to June 28, 2026 and the years ended June 29, 2025 and June 30, 2024, respectively.
Retirement Savings Plan
The Company sponsors one employee benefit plan (the "401(k) Plan") pursuant to Section 401(k) of the Internal Revenue Code. All United States employees are eligible to participate under the 401(k) Plan on the first day of a new fiscal month after the date of hire. Under the 401(k) Plan, there is no fixed dollar amount of retirement benefits; rather, the Company matches a defined percentage of employee deferrals, and employees vest in these matching funds over time. Employees choose their investment elections from a list of available investment options. For the period from June 30, 2025 to September 29, 2025 and the period from September 30, 2025 to June 28, 2026 and the years ended June 29, 2025 and June 30, 2024, the Company contributed approximately $2.1 million, $6.8 million, $12.1 million and $13.3 million to the 401(k) Plan, respectively.
Research and Development
Research and development expenses consist primarily of employee salaries and related compensation costs, occupancy costs, consulting costs and the cost of development equipment and supplies. Research and development activities are expensed when incurred.
Net (loss) Earnings Per Share
Basic net (loss) earnings per share is computed by dividing net (loss) income by the weighted average shares of common stock outstanding. Diluted earnings per share is determined in the same manner as basic (loss) earnings per share except that the number of shares is increased to assume exercise of potentially dilutive stock options, nonvested restricted stock, contingently issuable shares using the treasury stock method and the potential issuance of shares in connection with the Company's convertible notes using the if-converted method, unless the effect of such increases would be anti-dilutive.
Stock-Based Compensation
The Company accounts for its employee stock-based compensation plans using the fair value method. The fair value method requires the Company to estimate the grant-date fair value of its stock-based awards and amortize this fair value to compensation expense over the requisite service period or vesting term.
The Company’s stock-based awards can be either service-based or performance-based. Performance-based conditions may be tied to future financial and/or operating performance of the Company, external based market metrics or internal performance metrics.
For service-based restricted stock units ("RSUs") and performance-based RSUs with internal metrics, the grant-date fair value is based upon the market price of the Company’s common stock on the date of the grant. For performance-based RSUs, the Company reassesses the probability of the achievement of the performance condition at each reporting period and adjusts the compensation expense for subsequent changes in the estimate or actual outcome. This fair value is then amortized to compensation expense over the requisite service period or vesting term.
For performance-based awards with market conditions, the Company estimates the grant date fair value using the Monte Carlo valuation model and expenses the awards over the vesting period regardless of whether the market condition is ultimately satisfied.
The Company used the Black-Scholes option-pricing model to estimate the fair value of the Company’s Employee Stock Purchase Plan ("ESPP") awards. The determination of the fair value of stock-based payment awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables. These variables include the expected stock price volatility over the term of the awards, the risk-free interest rate and expected dividends. Due to the inherent limitations of option-valuation models, future events that are unpredictable and the estimation process utilized in determining the valuation of the stock-based awards, the ultimate value realized by award holders may vary significantly from the amounts expensed in the Company’s financial statements. In April 2025, the Compensation Committee approved the termination of the ESPP, which was effective immediately and as of June 28, 2026, the Company has not approved another employee stock purchase program.
Stock-based compensation expense is recognized ratably over the requisite service period of the awards, and the Company accounts for forfeitures when they occur.
See Note 14, "Stock-Based Compensation," for more information about the Company's stock-based compensation plans.
Taxes
The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets are recognized for deductible temporary differences, along with net operating loss carryforwards and credit carryforwards, if it is more likely than not that the tax benefits will be realized. To the extent a deferred tax asset cannot be recognized under the preceding criteria, valuation allowances are established. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. As a result of the implementation of the Plan, the Company's tax attributes will be subject to the attribute reduction rules under Section 108 of the Code, which will result in the reduction of pre-Chapter 11 net operating losses.
Taxes payable, which are not based on income, are accrued ratably over the period to which they apply. For example, payroll taxes are accrued each period end based upon the amount of payroll taxes that are owed as of that date; whereas taxes such as property taxes and franchise taxes are accrued over the fiscal year to which they apply if paid at the end of a period, or they are amortized ratably over the fiscal year if they are paid in advance.
Foreign Currency Translation
All of the Company's operations have a U.S. Dollar functional currency and therefore no foreign currency translation adjustments are recognized in other comprehensive loss in the consolidated statements of comprehensive loss. The Company and its subsidiaries transact business in currencies other than the U.S. Dollar and as such, the Company experiences varying amounts of foreign currency exchange gains and losses.
Accumulated Other Comprehensive Loss, net of taxes
Accumulated other comprehensive loss, net of taxes, consisted of $0.0 million and $3.8 million of net unrealized losses on available-for-sale securities as of June 28, 2026 and June 29, 2025, respectively. Amounts for June 29, 2025 include a $2.4 million loss related to tax on unrealized loss on available-for-sale securities.
Supplemental Cash Flow Information
Cash paid for interest, net of capitalized interest, was $38.4 million, $113.4 million, $130.3 million, and $213.5 million for the period from June 30, 2025 to September 29, 2025 and from September 30, 2025 to June 28, 2026 and the fiscal years ended June 29, 2025 and June 30, 2024, respectively.
Cash (received) paid for taxes, net of refunds received, was $0.2 million, $1.0 million, $0.8 million and $9.8 million for the period from June 30, 2025 to September 29, 2025 and from September 30, 2025 to June 28, 2026 and the fiscal years ended June 29, 2025 and June 30, 2024, respectively.
Statements of Cash Flows - non-cash activities
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended | | Fiscal Year Ended |
| | | June 29, 2025 | | June 30, 2024 |
| Lease asset and liability additions | $3.6 | | | $19.1 | | | $35.2 | | | $5.6 | |
| Lease asset and liability modifications, net | 0.2 | | | (0.2) | | | 3.2 | | | 4.4 | |
| Lease termination | (5.0) | | | (0.1) | | | — | | | — | |
| Lease impairment | — | | | — | | | (4.8) | | | — | |
| | | | | | | |
| Proceeds from sale of business received in common stock | — | | | — | | | — | | | 60.8 | |
| Decrease in property, plant and equipment from investment tax credit receivables | 64.2 | | | 76.8 | | | 303.3 | | | 474.4 | |
| | | | | | | |
| Receivable in connection with short-term investment maturities | — | | | — | | | — | | | 25.0 | |
| Decrease in property, plant and equipment from long-term incentive related receivables | — | | | — | | | — | | | 114.3 | |
| (Decrease) increase in accrued property, plant and equipment | (32.1) | | | (82.4) | | | (241.0) | | | 37.3 | |
Recently Adopted Accounting Pronouncements
In September 2025, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606) (“ASU 2025-07”). The guidance refines the scope of Topic 815 to clarify which contracts are subject to derivative accounting. The guidance also provides clarification under Topic 606 for share-based payments from a customer in a revenue contract. The amendments in ASU 2025-07 are effective for fiscal years and interim periods beginning after December 15, 2026, with early adoption permitted. The Company early adopted ASU 2025-07 on September 29, 2025, on a prospective basis, which includes the scope exception for derivatives, and the adoption did not have a material impact on our financial statements.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Tax Disclosures, which requires disaggregated information about an entity's income tax rate reconciliation as well as information regarding cash taxes paid both in the United States and foreign jurisdictions. The amendments should be applied prospectively, with retrospective application permitted. The amendments are effective for annual periods beginning after December 15, 2024 with early adoption permitted. The new standard requires additional disaggregation of certain information in the Company's tax footnote and the Company adopted ASU 2023-09 on a prospective basis beginning in this Annual Report on Form 10-K for the period ended June 28, 2026.
Recently Issued Accounting Pronouncements Pending Adoption
In November 2024, the FASB issued ASU 2024-03, Income Statement (Topic 220): Disaggregation of Income Statement Expenses, to require additional disclosures of certain amounts included in the expense captions presented on the Statement of Operations as well as disclosures about selling expenses. In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. ASU 2024-03 is effective on a prospective basis, with the option for retrospective application, for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, and early adoption is permitted. The Company is currently evaluating the impacts of adopting this guidance on its financial statement disclosures.
In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, which establishes authoritative guidance on the recognition, measurement, presentation, and disclosure of government grants. Under ASU 2025-10, government grants are recognized when it is probable that the entity will both comply with the conditions of the grant and the grant will be received. The ASU provides specific accounting models for grants related to assets and grants related to income, including options to recognize government grants as deferred income or as a reduction of the asset's cost basis. The ASU also requires enhanced disclosures regarding the nature of government grants, significant terms and conditions, accounting policies applied, and amounts recognized in the financial statements. ASU 2025-10 is effective for fiscal years beginning after December 15, 2028, including interim periods within those fiscal years, with early adoption permitted. The Company plans to adopt this pronouncement for its fiscal year beginning June 25, 2029.
Recently issued ASUs by the FASB, except for the ones mentioned above, are not expected to have a significant impact on the Company’s consolidated results of operations or financial position. Other accounting standards that have been issued or proposed by the FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its consolidated financial statement disclosures.
Note 3 - Emergence from Voluntary Reorganization under Chapter 11
On the Petition Date, the Debtors commenced the Chapter 11 Cases under the Bankruptcy Code in the Bankruptcy Court. On that date, the Debtors also filed the Plan with the Bankruptcy Court, and on September 8, 2025, the Bankruptcy Court entered the Confirmation Order. On the Effective Date, the Debtors emerged from the Chapter 11 Cases in accordance with the Plan.
Definitions
•Conversion Effective Time - the time of 12:01 am Eastern Time on September 29, 2025.
•Convertible Notes Claim - any Claim on account of the Convertible Notes or otherwise arising under indentures governing such notes, including accrued but unpaid interest thereon through the Petition Date.
•CRD Agreement Deposits - the term loans in an aggregate amount of $2.1 billion (including accrued and unpaid interest as of the Petition Date) made by Renesas to the Company under that certain Unsecured Customer Refundable Deposit Agreement, dated as of July 5, 2023, as amended to date, by and between Wolfspeed and Renesas.
•Professional Fee Escrow Account - an escrow account established and funded to pay for all Bankruptcy Court approved professional fees and expenses due from the Company.
•Regulatory Approvals - (a) Committee on Foreign Investment in the United States ("CFIUS") approval; (b) clearance or approval under antitrust laws in (i) the United States, (ii) Austria, (iii) Germany, (iv) Japan, and (v) European Commission (as applicable); (c) clearance or approval under Italy Foreign Investment Laws; (d) regulatory approvals from any regulatory regimes necessary to consummate the restructuring transactions (for the avoidance of doubt, in relation to the Regulatory Approvals, for Renesas to receive the New 2L Renesas Convertible Notes (as defined below); 16,852,372 shares of New Common Stock (as defined below) underlying the Renesas Warrants; and voting, board seat, and other governance rights in accordance with the Restructuring Support Agreement), that are identified by Renesas and of which the Debtors are notified within thirty (30) calendar days following the effective date of the Restructuring Support Agreement; and (e) any regulatory approvals from any regulatory regimes necessary to consummate the restructuring transactions that are not identified by Renesas and of which the Debtors are not notified within thirty (30) calendar days following the effective date of the Restructuring Support Agreement. All Regulatory Approvals were obtained as of January 29, 2026, which was prior to the Regulatory Trigger Deadline.
•Regulatory Trigger Deadline - the earlier of (i) a good faith agreement between the Debtors or Reorganized Debtors, which means the Debtors on and after the Effective Date, and Renesas that it is more likely than not that the Regulatory Approvals will not be obtained and (ii) two (2) years from the Effective Date; provided, if upon two (2) years from the Effective Date, the Reorganized Debtors and Renesas agree, in good faith, that Regulatory Approval is more likely than not to be obtained prior to three (3) years from the Effective Date, then upon three (3) years from the Effective Date. For the avoidance of doubt, to the extent Renesas obtains all Regulatory Approvals prior to the date of the Regulatory Trigger Deadline, the Regulatory Trigger Deadline shall be deemed not to have occurred. All Regulatory Approvals were obtained as of January 29, 2026, which was prior to the Regulatory Trigger Deadline.
•Senior Secured Notes Claim - any claim on account of the Existing Senior Secured Notes or otherwise arising under the Senior Secured Notes Documents (as defined in the Plan).
Plan of Reorganization
On the Effective Date, the Company emerged from the Chapter 11 Cases as all the material conditions precedent to the effectiveness of the Plan were satisfied or waived and the Plan became effective. In accordance with the Plan and effective as of the Effective Date:
•Cancellation of Prior Equity Interests – Immediately prior to the Effective Date there were 156,479,390 shares of the Company's common stock, $0.00125 par value per share (the "Old Common Stock"), outstanding. In accordance with the Plan and the Plan of Conversion at the Conversion Effective Time, the Company effected a redomestication from a North Carolina corporation to a Delaware corporation and, in connection therewith, adopted a new certificate of incorporation, under which the Company is authorized to issue 350,000,000 shares of common stock, $0.00125 par value per share ("New Common Stock"), and new bylaws, each of which became effective at the Conversion Effective Time. After giving effect to the transactions contemplated by the Plan and the Plan of Conversion, on the Effective Date all of the previously issued and outstanding shares of Old Common Stock were cancelled, and existing equity holders received their pro rata share of approximately 1,306,896 shares of New Common Stock, of the Delaware corporation. Pursuant to the Plan, the Company issued an aggregate of 25,840,656 shares of New Common Stock (inclusive of the aforementioned shares of New Common Stock issued to existing equity holders, with the remaining shares issued to pre-petition convertible noteholders, in accordance with the Plan). As of the Effective Date, the Company had an aggregate of 25,840,656 shares of New Common Stock issued and outstanding and 73,030,424 shares of New Common Stock reserved for issuance pursuant to the Plan (the "Share Reserve").
•Secured Financing – The Existing Senior Secured Notes were discharged and terminated. Each holder of a Senior Secured Notes Claim received on account of their claims: (a) their pro rata portion of the $1.3 billion principal amount of new Senior Secured Notes due 2030 (the "New Senior Secured Notes"), (b) a pro rata redemption of $277.5 million in principal amount of Existing Senior Secured Notes at 109.875% of the principal amount being redeemed (paid with the proceeds of the rights offering, described below, and proceeds from the sale of the MACOM Shares (as defined below), and (c) certain commitment fees, subject to certain conditions.
•Convertible Notes – The then-outstanding Convertible Notes totaling approximately $3.1 billion were discharged and terminated. Each holder of a Convertible Notes Claim received on account of their claims: (a) rights to participate in the rights offering of New 2L Non-Renesas Convertible Notes in the aggregate principal amount of approximately $301.1 million, which were offered at a purchase price of 91.3242% totaling $275.0 million, and fully backstopped by the Backstop Parties, and for which such Backstop Parties received a premium in the amount of $30.3 million for an aggregate principal amount of $331.4 million, (b) 7%/12% second lien senior secured PIK toggle notes due 2031 (the "New 2L Non-Convertible Notes") in an aggregate principal amount of $296.4 million, and (c) 24,533,760 shares of New Common Stock. Refer to Note 2, "Basis of Presentation and Summary of Significant Accounting Policies," and Note 11, “Debt,” for additional information on the New 2L Non-Renesas Convertible Notes and New 2L Non-Convertible Notes.
◦Registration Rights Agreement - On the Effective Date, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Renesas and certain holders of the New 2L Non‑Renesas Convertible Notes (the “RRA Counterparties”). The Registration Rights Agreement provides the RRA Counterparties with registration rights for their “Registrable Securities.” The Company was required to file a Shelf Registration Statement on Form S‑1 or Form S‑3 (i) within 45 days of the Effective Date (satisfied by a Form S‑1 filed November 13, 2025) and (ii) for Registrable Securities held by Renesas, within 45 days of the Renesas Base Distribution Date (as defined in the Plan), which obligation was fulfilled by the filing of a Registration Statement on Form S-1 on March 9, 2026 (the "Form S-1"). Following effectiveness of the Form S-1 on March 18, 2026, an RRA Counterparty may request an underwritten offering, with related filings due within fifteen business days. Registrable Securities may also be sold in non‑underwritten offerings. Shelf Registration Statements must remain effective until the covered securities cease to be Registrable Securities.
The RRA Counterparties have customary piggyback rights, subject to the limitations in the Registration Rights Agreement. The Company generally bears all registration expenses. The Registration Rights
Agreement includes customary indemnification and contribution provisions and terminates for each RRA Counterparty when it no longer holds Registrable Securities, and in full when no Registrable Securities remain outstanding.
•Renesas – The then-outstanding CRD Agreement Deposits with Renesas totaling approximately $2.1 billion were discharged and terminated. Renesas received on account of their claims: (a) a principal amount of approximately $203.6 million of New 2L Renesas Convertible Notes, (b) a warrant to purchase an aggregate of 4,943,555 shares of New Common Stock, at an exercise price of $23.95 per share (the "Renesas Warrant"), which until all Regulatory Approvals were received, were only deemed issued for purposes of U.S. federal and applicable state and local income tax purposes and were not exercisable, and (c) 16,852,372 shares of New Common Stock from the Share Reserve, the issuance of which was subject to Regulatory Approvals. All Regulatory Approvals were received in January 2026. As of June 28, 2026, the 16,852,372 shares of New Common Stock were issued to Renesas to settle the equity contract, resulting in the extinguishment of the forward equity contract liability. Additionally, as of June 28, 2026, the Renesas Warrant was reclassified from a liability to equity and the conversion feature bifurcated from the New 2L Renesas Convertible Notes was reclassified from liability to equity, upon meeting the criteria for equity classification subsequent to the Regulatory Approvals being received. Refer to Note 9, "Fair Value of Financial Instruments" and Note 11, “Debt” for additional information on the forward equity contract and the Renesas Warrant.
◦Investor Rights and Disposition Agreement - On the Effective Date, the Company entered into an Investor Rights and Disposition Agreement (the “Investor Rights Agreement”) with Renesas. The Investor Rights Agreement grants Renesas certain investment rights, including the right to designate one Board member, subject to receipt of Regulatory Approvals and Renesas holding more than 10% of the New Common Stock. The Investor Rights Agreement includes (i) a limitation preventing Renesas from exercising voting rights on New Common Stock beneficially owned in excess of 9.9% of the Aggregate Company Voting Power (the “Voting Rights Limitation”) and (ii) a limitation under which any conversion or exercise of Securities resulting in Renesas beneficially owning more than 39.9% of the Aggregate Company Voting Power is null and void (the “Beneficial Ownership Limitation,” and together with the Voting Rights Limitation, the “Limitations”). The Limitations apply through January 1, 2027 and automatically renew annually, unless earlier terminated by Renesas pursuant to the terms of the Investor Rights Agreement. Renesas may terminate the Limitations at any time if the Company submits to stockholders proposals involving a change of control, issuance of New Common Stock (or convertible/exercisable instruments), amendments to the certificate of incorporation or bylaws adversely affecting Renesas’s rights, or other matters adversely affecting such rights.
◦Renesas Contingent Consideration – As Regulatory Approvals were obtained prior to the Regulatory Trigger Deadline, Renesas is not entitled to the contingent consideration provided for under the Plan and $10 million of the cash placed into escrow upon emergence was remitted back to the Company, and $5 million of the cash placed into escrow upon emergence was remitted to the holders of the Existing Senior Secured Notes (on account of the commitment fee amount), the additional New 2L Non-Convertible Notes will not be issued, the 871,287 shares of New Common Stock were distributed to the holders of Old Common Stock immediately prior to the Effective Date, and the term of the Renesas Warrant will not be extended. Refer to Note 2, "Basis of Presentation and Summary of Significant Accounting Policies" and Note 16, “Commitments and Contingencies” for additional information.
◦Contingent Shares – As the Regulatory Approvals were obtained in the third quarter of fiscal 2026, prior to the Regulatory Trigger Deadline, the holders of Old Common Stock immediately prior to the Effective Date received their pro rata portion of 871,287 shares of New Common Stock from the Share Reserve (the “Contingent Shares”).
•Incentive Compensation Plans – Pursuant to the Plan, the Company adopted two equity compensation plans: the Long-Term Incentive Plan and the Management Incentive Plan, which each provide for the grant of options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance stock units, performance units, other awards, or a combination thereof. An aggregate of 4,058,925 shares of New Common Stock have been reserved for issuance under the Long-Term Incentive Plan. The Long-Term Incentive Plan provides for grants to be made under the Long-Term Incentive Plan in fiscal years 2026 and 2027 having an aggregate value, as determined by the Board or the Committee (as defined in the Long-Term Incentive Plan), equal to $26.6 million and $27.5 million,
respectively. An aggregate of 8,117,851 shares of New Common Stock have been reserved for issuance under the Management Incentive Plan. The Management Incentive Plan provides for initial awards under the Management Incentive Plan to be made to executive officers and key employees in accordance with the Restructuring Support Agreement. Any such awards are subject to approval by the Board of Directors. Please refer to Note 2, "Basis of Presentation and Summary of Significant Accounting Policies," and Note 14, "Stock-Based Compensation" for additional information on the Incentive Compensation Plans.
•Professional Fee Escrow Account – The Company funded the Professional Fee Escrow Account, which was reflected as restricted cash on the consolidated balance sheet. As of June 28, 2026 the professional fees for certain company advisers incurred during the Chapter 11 Cases subject to disbursements through the escrow account had been paid in full.
•General Unsecured Claims – Holders of general unsecured claims received payment in full in cash, reimbursement, or such other treatment rendering such general unsecured claims unimpaired. The Company has substantially completed its claims reconciliation process, and is working to settle all remaining outstanding prepetition claims in the ordinary course.
•Certificate of Incorporation – Please refer to Note 2, "Basis of Presentation and Summary of Significant Accounting Policies," for additional information on the Certificate of Incorporation. The Company effected a conversion from a North Carolina corporation to a Delaware corporation and, in connection therewith, adopted a new certificate of incorporation, under which the Company is authorized to issue 350,000,000 shares of New Common Stock and new bylaws, each of which became effective on the Effective Date.
Regulatory Approvals
The Regulatory Approvals were received on January 29, 2026, prior to the Regulatory Trigger Deadline. As set forth in the Plan, the Company issued 16,852,372 shares of New Common Stock to Renesas from the Share Reserve on January 29, 2026, and holders of Old Common Stock immediately prior to the Effective Date received their pro rata portion of the Contingent Shares.
The Company received $10 million of the cash that was placed into escrow upon emergence (the "Contingent Cash"), with the remaining $5 million going to holders of the Existing Senior Secured Notes. The $10 million Contingent Cash is recognized as a gain within "Non-operating income" on the Company's accompanying consolidated statement of operations for the period from September 30, 2025 to June 28, 2026.
The Regulatory Approvals were received in January 2026, which is reflected on the Company's consolidated balance sheet as of June 28, 2026. The following paragraphs summarize the recognition and measurement of amounts related to the Regulatory Approvals:
•Renesas Shares - the obligation to issue 16,852,372 shares to Renesas was recognized at fair value at $292.1 million as of the date on which all Regulatory Approvals were received and the forward equity contract liability was extinguished.
•Renesas Warrant - the warrant to purchase 4,943,555 shares upon receipt of the Regulatory Approvals qualified for equity-classification, and $31.5 million was reclassified to equity based on its fair value as of the date on which the Regulatory Approvals were received.
•Renesas 2L Convertible Notes - the embedded conversion feature on the Renesas 2L Convertible notes was bifurcated from the underlying debt instrument and remeasured to fair value as of the date on which the Regulatory Approvals were received. Upon receipt of the Regulatory Approvals, the conversion feature qualified for equity-classification, and $87.9 million was reclassified to equity based on the fair value as of the approval date.
•Additional 2L Non-Convertible Notes - the receipt of the Regulatory Approvals nullified the potential obligation to issue the Additional 2L Non-Convertible Notes.
•Contingent Shares - the obligation to issue 871,287 shares to holders of Old Common Stock upon receipt of the Regulatory Approvals was completed and increased the Company's total shares outstanding.
•Contingent Cash - the $10 million of the Contingent Consideration was remitted to the Company and is treated as a gain in non-operating income during the third quarter of fiscal 2026. The outflow and inflow associated with this amount was recorded within "Cash used in financing activities".
New Senior Secured Notes
On the Effective Date, the Company entered into that certain Indenture (the “New Senior Secured Notes Indenture”), by and among the Company, Wolfspeed Texas, as subsidiary guarantor (the “Subsidiary Guarantor”), and U.S. Bank Trust Company, National Association, as the trustee (the “Trustee”) and collateral agent (the “Collateral Agent”), pursuant to which, among other things, the Company issued the New Senior Secured Notes. Refer to Note 11, "Debt," for additional information on the New Senior Secured Notes.
The New Senior Secured Notes bear interest, payable quarterly in arrears on March 23, June 23, September 23, and December 23 of each year, (a) for the period from the Effective Date through and including June 22, 2026, at a rate of 9.875% per annum (payable in cash), plus 4.00% per annum (payable in-kind); and (b) for the period commencing on June 23, 2026 and at all times thereafter, (i) if the Interest Rate Step-Down Condition (as described below) is satisfied as of June 23 of the most recent year, at a rate of 13.875% per annum (payable in cash) and (ii) if the Interest Rate Step-Down Condition is not satisfied as of June 23 of the most recent year, at a rate of 15.875% per annum (payable in cash). The Interest Rate Step-Down Condition is met if (a)(i) the Company redeems or repurchases (other than redemptions or repurchases with the proceeds of dispositions) the New Senior Secured Notes, resulting in the aggregate principal amount of New Senior Secured Notes outstanding being less than $1,000,000,000 and (ii) the Company receives at least $450,000,000 of award disbursements pursuant to governmental grants under the CHIPS Act or (b) as of the most recent June 23rd, the ratio of the outstanding principal amount of the New Senior Secured Notes to EBITDA (as defined in the New Senior Secured Notes Indenture) for the most recently ended four fiscal quarter period for which financial statements have been or are required to have been delivered under the New Senior Secured Notes Indenture is less than or equal to 2.00:1.00. The New Senior Secured Notes will mature on June 23, 2030. The Company did not meet the conditions as of June 23, 2026 for the interest rate step-down.
The New Senior Secured Notes Indenture requires the Company to make an offer to repurchase the New Senior Secured Notes with 100% of the net cash proceeds of certain extraordinary receipts, at a price of 109.875% of the principal amount plus accrued and unpaid interest upon the first to occur of the following : (i) in the event the Company and/or its subsidiaries receive in excess of $200,000,000 of such extraordinary receipts from the Effective Date through June 22, 2026, such offer to repurchase will be required to be in an aggregate principal amount of $175,000,000 of the New Senior Secured Notes, (ii) in the event the Company and/or its subsidiaries receive in excess of $200,000,000 of such extraordinary receipts from the Effective Date through June 22, 2027, such offer to repurchase will be required to be in an aggregate principal amount of $225,000,000 of the New Senior Secured Notes, or (iii) if the Company and/or its subsidiaries receive less than or equal to $200,000,000 of such extraordinary receipts from the Effective Date through June 22, 2027, such offer to repurchase will be required to be in an aggregate principal amount of $150,000,000 (such repurchase date, the “Extraordinary Receipts Trigger Date”). The Extraordinary Receipts Trigger Date occured during the period from September 30, 2025 to June 28, 2026 when we received the cash from the investment tax credit receivable, and the $175.0 million was paid during the period ended June 28, 2026.
Further, the Company is required to repurchase the New Senior Secured Notes with 100% of the net cash proceeds of certain non-ordinary course asset sales and casualty events, subject to the ability to (so long as no default or event of default exists under the New Senior Secured Notes Indenture), reinvest the proceeds of casualty events involving certain core assets, at a price equal to the lesser of (a) 111.875% of the principal amount of the New Senior Secured Notes being repurchased and (b) if such disposition or casualty event occurred (i) on or after June 23, 2026 and prior to the later of June 23, 2027 and the Extraordinary Receipts Trigger Date, 109.875% of the principal amount of such New Senior Secured Notes, plus accrued and unpaid interest to, but excluding, the applicable redemption (or repurchase) date, (ii) on or after the later of June 23, 2027 and the Extraordinary Receipts Trigger Date and prior to June 23, 2028, 105.000% of the principal amount of such New Senior Secured Notes, plus accrued and unpaid interest to, but excluding, the applicable redemption (or repurchase) date, (iii) on or after June 23, 2028 and prior to June 23, 2029, 103.000% of the principal amount of such New Senior Secured Notes, plus accrued and unpaid interest to, but excluding, the applicable redemption (or repurchase) date, and (iv) on or after June 23, 2029, 100% of the principal amount of such New Senior Secured Notes plus accrued and unpaid interest to, but excluding, the applicable redemption (or repurchase) date (this clause (b), the “Applicable Redemption Price”). The Company is also required to offer to repurchase the New Senior Secured Notes upon a change in control, at a price equal to, (a) if such change of control occurs prior to June 23, 2026, the greater of (i) a customary make-whole redemption price minus 1.00% of the principal amount of such New Senior Secured Notes and (ii) the Applicable Redemption Price as of June 23, 2026 and (b) if such change of control occurs on or after June 23, 2026, the Applicable Redemption Price at the time such change of control occurs. The Company may redeem the New Senior Secured Notes at any time, subject to, (a) if the redemption occurs prior to June 23, 2026, by paying a customary make-whole premium and (b) if the redemption occurs on or after June 23, 2026, by paying the Applicable Redemption Price. Further, the Company had the right, prior to June 23, 2026, to make an optional redemption of up to 35% of
the New Senior Secured Notes with the proceeds of qualified equity issuances consummated since the Effective Date (provided that the Company has received at least $300,000,000 of net proceeds from such equity issuances), at a redemption price equal to 111.875%. The Company did not take action on this right.
The New Senior Secured Notes Indenture contains certain customary affirmative covenants, negative covenants, and events of default, including a minimum liquidity financial covenant requiring the Company to have an aggregate amount of unrestricted cash and cash equivalents maintained in accounts over which the Collateral Agent has been granted a perfected first lien security interest of at least $350,000,000 as of the last day of any calendar month.
The obligations of the Company under the New Senior Secured Notes Indenture will be guaranteed by the Company’s material subsidiaries, if any, subject to certain exceptions, and are secured by a pledge (and, with respect to real property, mortgage) of substantially all of the existing and future property and assets of the Company and the guarantors (subject to certain exceptions), including a pledge of the capital stock of the subsidiaries of the Company and the guarantors, subject to certain exceptions.
New 2L Renesas Convertible Notes, New 2L Non-Renesas Convertible Notes and New 2L Non-Convertible Notes
On the Effective Date, the Company entered into (i) that certain indenture (the “New 2L Renesas Convertible Notes Indenture”), by and among the Company, the Subsidiary Guarantor, and the Trustee and the Collateral Agent in respect of the new 2.5% Convertible Second-Lien Senior Secured Notes due 2031 issued to Renesas (the "New 2L Renesas Convertible Notes"), (ii) that certain indenture (the “New 2L Non-Renesas Convertible Notes Indenture”), by and among the Company, the Subsidiary Guarantor, the Trustee and the Collateral Agent in respect of the New 2L Non-Renesas Convertible Notes and (iii) that certain indenture (the “New 2L Non-Convertible Notes Indenture” and, together with the New 2L Renesas Convertible Notes Indenture and the New 2L Non-Renesas Convertible Notes Indenture, the “2L Indentures”), by and among the Company, the Subsidiary Guarantor, the Trustee and the Collateral Agent in respect of the New 2L Non-Convertible Notes (together with the New 2L Renesas Convertible Notes and the New 2L Non-Renesas Convertible Notes, collectively, the “2L Notes”).
The 2L Notes bear interest, payable semi-annually in arrears on June 15 and September 15 of each year to the holders of record as of June 1 and September 1 of each year. Interest on the New 2L Renesas Convertible Notes and the New 2L Non-Renesas Convertible Notes is required to be paid in cash; interest on the New 2L Non-Convertible Notes is permitted to be paid either in cash or in kind (at the Company’s election), at an interest rate of 7.00% or 12.00%, respectively. The 2L Notes mature, in each case, on June 15, 2031.
Each of the New 2L Renesas Convertible Notes and New 2L Non-Renesas Convertible Notes (collectively, the “2L Convertible Notes”) are convertible pursuant to the terms of the New 2L Renesas Convertible Notes Indenture and the New 2L Non-Renesas Convertible Notes Indenture, respectively. The New 2L Renesas Convertible Notes are convertible at any time from and after September 29, 2025 until the fifth trading day immediately preceding September 29, 2027 (the “Conversion Expiration Date”), provided that the New 2L Renesas Convertible Notes were not convertible until the Renesas Base Distribution Date which occurred in January 2026, and the New 2L Non-Renesas Convertible Notes are convertible at any time from and after September 29, 2025 until the fifth (5th) scheduled trading day immediately preceding the maturity date, in each case, subject to certain limitations and exceptions. The 2L Convertible Notes are convertible into cash, common stock of the Company or a combination thereof, at the Company’s election. The 2L Convertible Notes will be entitled to customary anti-dilutive measures (including adjustments to the 2L Convertible Notes’ conversion rates), as described in each of the indentures governing the 2L Convertible Notes.
The New 2L Renesas Convertible Notes are not permitted to be redeemed prior to the date that is two years following the Effective Date; the New 2L Non-Renesas Convertible Notes are not permitted to be redeemed prior to the date that is three years following the Effective Date. In the event of an optional redemption by the Company, holders will be entitled to a cash redemption price equal to 100% of the principal amount of such note redeemed, plus accrued and unpaid interest (any such redemption, an “Optional Redemption”).
The Company is required to offer to repurchase the 2L Notes upon a change of control and, in the case of (i) the 2L Convertible Notes, at a cash repurchase price equal to 100% of the principal amount of such note repurchased, plus accrued and unpaid interest and (ii) the New 2L Non-Convertible Notes, at a cash repurchase price equal to 101% of the principal amount of such note repurchased, plus accrued and unpaid interest. Following the Conversion Expiration Date and upon the occurrence of a change of control, the New 2L Renesas Convertible Notes will be entitled to a cash repurchase price consistent with that of the New 2L Non-Convertible Notes. Holders of the 2L Convertible Notes will be entitled to make-whole adjustments to the respective conversion rates in the event of a change of control or an Optional Redemption. Notwithstanding the foregoing (but subject to certain limitations described in the indentures governing the 2L Convertible Notes), holders of the 2L Convertible Notes are permitted to convert their notes (i) in lieu of redemption in the event of an Optional Redemption by the Company or (ii) upon the occurrence of a change of control. The Company is also required, subject to the terms of the New Senior Secured
Notes and pursuant to the terms and conditions set forth in the indentures governing the 2L Notes, to make an offer to purchase the 2L Notes, on a pro rata basis, upon the occurrence of certain non-ordinary course asset sales and casualty events (subject to certain reinvestment rights described in the 2L Indentures).
The 2L Indentures contain certain customary affirmative covenants, negative covenants, and events of default.
The obligations of the Company under the 2L Indentures will be guaranteed by the Company’s material subsidiaries, if any, subject to certain exceptions, and are secured on a second-priority basis by liens on substantially all of the existing and future property and assets of the Company and the guarantors (subject to certain exceptions) that secure the New Senior Secured Notes.
Intercreditor Agreements
In connection with the Company’s entrance into the New Senior Secured Notes Indenture and the 2L Indentures, the Company, Wolfspeed Texas, as a guarantor, and the trustees and the collateral agents under each of the New Senior Secured Notes Indenture and the 2L Indentures entered into the First Lien/Second Lien Intercreditor Agreement, dated as of September 29, 2025 (the "1L/2L Intercreditor Agreement"), which sets forth the respective rights on the shared collateral between the noteholders under the New Senior Secured Notes, as first lien creditors, on the one hand, and the noteholders under the 2L Notes, as second lien creditors, on the other hand. Additionally, in connection with the Company’s entrance into the 2L Indentures, the Company, Wolfspeed Texas, as a guarantor, and the trustees and the collateral agents under each of the 2L Indentures entered into the Equal Priority Intercreditor Agreement, dated as of September 29, 2025, which sets forth the respective rights on the shared collateral among the noteholders under the 2L Notes.
Reorganization items, net
Reorganization items incurred as a result of the Chapter 11 Cases are presented separately in the Consolidated Statement of Operations. The table below presents the reorganization items as a result of the Chapter 11 Cases during the periods presented:
| | | | | | | | | | | | | | |
| Successor | Predecessor |
(in millions of U.S. dollars) | Period from September 30, 2025 through June 28, 2026 | Period from June 30, 2025 through September 29, 2025 | Fiscal Year Ended June 29, 2025 | Fiscal Year Ended June 30, 2024 |
Allowed claims adjustments | $— | | $475.7 | | $— | | $— | |
| Success fees | — | | 34.0 | | — | | — | |
Professional fees | — | | 28.2 | | — | | — | |
Gain on settlement of liabilities subject to compromise | — | | (3,751.8) | | — | | — | |
Write-off related to Predecessor directors’ and officers’ insurance policy | — | | 3.6 | | — | | — | |
Cancellation of unvested Predecessor stock compensation awards | — | | 61.5 | | — | | — | |
| | | | |
Fresh start valuation adjustments | — | | 2,585.4 | | — | | — | |
Reorganization items, net | $— | | ($563.4) | | $— | | $— | |
| | | | |
Cash payments for Reorganization items, net | $23.7 | | $38.5 | | $— | | $— | |
Note 4 - Fresh Start Accounting
Fresh Start
In connection with the Company's emergence from the Chapter 11 Cases and in accordance with ASC 852, the Company qualified for and adopted fresh start accounting on the Effective Date. The Company was required to adopt fresh start accounting because (i) the holders of voting shares of the Predecessor received less than 50% of the voting shares of the Successor and (ii) the $3.8 billion reorganization value of the Company's assets immediately prior to confirmation of the Plan was less than the approximately $7.6 billion of post-petition liabilities and allowed claims.
In accordance with ASC 852, with the adoption of fresh start accounting, the Company allocated the reorganization value to its individual assets and liabilities based on their estimated fair values in conformity with ASC Topic 805, Business Combinations (the reorganization value represents the fair value of the Successor assets before considering liabilities). As a result of the adoption of fresh start accounting and the effects of the implementation of the Plan, the consolidated financial statements after September 29, 2025 are not comparable with the consolidated financial statements as of or prior to that date.
Reorganization Value
Management, with the assistance of valuation advisors, estimated the enterprise value of the Successor to be between $2,350 million and $2,850 million, which was approved by the Bankruptcy Court. Based on the estimates and assumptions discussed below, the Company estimated the enterprise value to be $2,600 million, which is the mid-point of the range of the enterprise value.
The enterprise value was estimated using an income approach that utilizes a discounted cash flow model. The net cash flows were discounted using an after-tax weighted average cost of capital ("WACC") methodology reflecting a rate of return that would be expected by a market participant. The WACC methodology also takes into consideration a company-specific risk premium reflecting the risk associated with the financial projections used to estimate future cash flows. The present value of future expected net cash flows projected through 2034 is calculated using an estimated discount rate of 20.1%.
The enterprise value and corresponding equity value are dependent upon achieving the future financial results set forth in the Company's projections. All estimates, assumptions, valuations and financial projections, including the fair value adjustments, the estimated enterprise value and estimated equity value, are inherently subject to uncertainties and the resolution of contingencies beyond the Company's control. Accordingly, there can be no assurance that the estimates, assumptions, valuations and financial projections will be realized, and actual results could vary materially. Moreover, the value of the New Common Stock may differ materially from the implied values at the Effective Date in the financial statements.
A reconciliation of the enterprise value to the implied value of New Common Stock and reorganization value is set forth below:
| | | | | |
| |
(in millions of U.S. Dollars) | |
| Enterprise value | $2,600.0 | |
| Plus: Cash and cash equivalents (includes restricted cash) and short-term investments | 835.4 | |
| Less: Fair value of debt issued upon emergence, including issuance costs, excluding equity-classified substantial premium | (2,151.3) | |
| Less: Equity-classified substantial premium associated with New 2L Non-Renesas Convertible Notes | (168.8) | |
| Less: Fair value of the Renesas Warrant | (33.6) | |
| Less: Cash from MACOM Shares sale captured in enterprise value | (60.8) | |
| Less: Deposit liabilities included in cash | (25.2) | |
| Less: Debt issuance costs | (8.0) | |
| Less: Restricted cash | (28.3) | |
| Implied value of Wolfspeed, Inc's common stock (including reserved but unissued shares) | $959.4 | |
| Less: Implied value of the Renesas Base Consideration Shares classified as a liability | ($371.1) | |
| Less: Implied value of the obligation to issue Contingent Shares classified as equity | ($19.2) | |
| Implied value of Wolfspeed, Inc's common stock outstanding as of the Effective Date | $569.1 | |
| Plus: Equity-classified substantial premium associated with New 2L Non-Renesas Convertible Notes | $168.8 | |
| Plus: Implied value of the obligation to issue Contingent Shares classified as equity | $19.2 | |
| Total stockholders' equity as of the Effective Date | $757.1 | |
The reconciliation of the Company's enterprise value to reorganization value as of the Effective Date is as follows:
| | | | | |
(in millions of U.S. Dollars) | |
| Enterprise value | $2,600.0 | |
| Plus: Cash and cash equivalents (includes restricted cash) and short-term investments | 835.4 | |
| Plus: Current liabilities excluding debt | 340.4 | |
| Plus: Long-term liabilities excluding debt | 184.6 | |
| Less: Cash from MACOM Shares sale captured in enterprise value | (60.8) | |
| Less: Deposit liabilities included in cash | (25.2) | |
| Less: Debt issuance costs | (8.0) | |
| Less: Restricted cash | (28.3) | |
| Reorganization value | $3,838.1 | |
Intangible Assets
The identified intangible assets of $445.7 million, which principally consisted of developed technology, trade name, patents and licensing rights, and customer relationships, were estimated based on the relief from royalty income approach used by management in the valuation of developed technology and trade name and the multi period excess earnings method used by management in the valuation of customer relationships. Significant assumptions used by management in the valuation of developed technology and trade name related to royalty rates, discount rates, and revenue growth rates and significant assumptions used by management in the valuation of customer relationships related to revenue growth rates, attrition rate, margins, contributory asset charges, discount rate and economic lives. Such fair value measurement of intangible assets is considered Level 3 of the fair value hierarchy. For the technology-based intangibles that were valued using the relief from royalty income approach, the royalty rates were estimated to be 5% or 15% and the discount rate 21%. For trade names and trademarks valued under the relief from royalty income approach, the royalty rate was estimated to be 0.5% and the discount rate 20.5%. For customer-related intangible assets that were valued using the multi-period excess earnings method, the attrition rate were estimated to be 10% or 17.5% and the discount rate 22.5%.
Lease Liabilities and Right of Use Assets
The present value of lease liabilities was measured as the present value of the remaining lease payments, as if the leases were new leases as of the Effective Date. The Company used its incremental borrowing rate (“IBR”) as the discount rate in determining the present value of the remaining lease payments using a fundamental credit rating analysis. Based upon the corresponding lease terms, the IBRs ranged between approximately 9.9%-13.9%. Right of use asset values were estimated based on the lease liability.
Consolidated Balance Sheet
The adjustments set forth in the following consolidated balance sheet as of September 29, 2025 reflect the effects of the transactions contemplated by the Plan and executed on the Effective Date (reflected in the column "Reorganization Adjustments") and fair value accounting adjustments resulting from the adoption of fresh start accounting (reflected in the column "Fresh Start Adjustments"). The explanatory notes provide additional information with regard to the adjustments recorded.
| | | | | | | | | | | | | | | | | | | | | | | |
| As of September 29, 2025 |
| Predecessor | | Reorganization Adjustments | | Fresh-Start Adjustments | | Successor |
| Assets | | | | | | | |
| Current assets: | | | | | | | |
| Cash and cash equivalents (includes restricted cash) | $571.6 | | | (90.6) | | (1) | — | | | $481.0 | |
| Short-term investments | 354.4 | | | — | | | — | | | 354.4 | |
| Total cash, cash equivalents and short-term investments | 926.0 | | | (90.6) | | | — | | | 835.4 | |
| Accounts receivable, net | 155.6 | | | — | | | — | | | 155.6 | |
| Inventories, net | 385.5 | | | — | | | 6.8 | | (14) | 392.3 | |
| Prepaid expenses | 75.5 | | | (3.6) | | (2) | (0.1) | | (15) | 71.8 | |
| Investment tax credit receivable | 654.0 | | | — | | | — | | | 654.0 | |
| Other current assets | 118.3 | | | — | | | 1.6 | | (16) | 119.9 | |
| | | | | | | |
| Total current assets | 2,314.9 | | | (94.2) | | | 8.3 | | | 2229.0 |
| Property and equipment, net | 3,775.8 | | | — | | | (3,006.6) | | (17) | 769.2 | |
| Intangible assets, net | 24.2 | | | — | | | 421.5 | | (18) | 445.7 | |
| Long-term investment tax credit receivable | 181.3 | | | — | | | — | | | 181.3 | |
| Other assets | 254.9 | | | — | | | (42.0) | | (19) | 212.9 | |
| Total assets | $6,551.1 | | | (94.2) | | | (2,618.8) | | | $3,838.1 | |
| | | | | | | |
| Liabilities and Stockholders' Equity | | | | | | | |
| Current liabilities: | | | | | | | |
| Accounts payable and accrued expenses | $196.5 | | | 10.3 | | (3) | — | | | $206.8 | |
| Contract liabilities and distributor-related reserves | 72.9 | | | — | | | — | | | 72.9 | |
| Income taxes payable | 0.9 | | | — | | | — | | | 0.9 | |
| Finance lease liabilities | — | | | 0.6 | | (4) | — | | | 0.6 | |
| Other current liabilities | 29.3 | | | 26.1 | | (6) | 4.4 | | (20) | 59.8 | |
| Total current liabilities | 299.6 | | | 37.0 | | | 4.4 | | | 341.0 | |
| Long-term liabilities: | | | | | | | |
| Long-term debt | — | | | 1,609.0 | | (7) | — | | | 1,609.0 | |
| Convertible notes, net | — | | | 539.7 | | (8) | — | | | 539.7 | |
| Finance lease liabilities - long-term | — | | | 8.3 | | (4) | (6.4) | | (21) | 1.9 | |
| Long-term warrant | — | | | 33.6 | | (5) | — | | | 33.6 | |
| Forward equity contract | — | | | 371.1 | | (5) | — | | | 371.1 | |
| Other long-term liabilities | 16.6 | | | 201.5 | | (9) | (33.4) | | (22) | 184.7 | |
| Liabilities subject to compromise | 7,315.3 | | | (7,315.3) | | (10) | — | | | — | |
| Total liabilities | 7,631.5 | | | (4,515.1) | | | (35.4) | | | 3,081.0 | |
| Commitments and contingencies | | | | | | | |
| Stockholders’ equity: | | | | | | | |
| Predecessor common stock | 0.2 | | | (0.2) | | (11) | — | | | — | |
| Successor common stock | — | | | — | | (12) | — | | | — | |
| Predecessor additional paid-in-capital | 4,103.6 | | | (4,103.6) | | (11) | — | | | — | |
| Successor additional paid-in-capital | — | | | 757.1 | | (12) | — | | | 757.1 | |
| Accumulated other comprehensive loss | (3.0) | | | — | | | 3.0 | | (23) | — | |
| Accumulated deficit | (5,181.2) | | | 7,767.6 | | (13) | (2,586.4) | | (23) | — | |
| Total stockholders’ equity | (1,080.4) | | | 4,420.9 | | | (2,583.4) | | | 757.1 | |
| | | | | | | |
| | | | | | | |
| Total liabilities and stockholders’ equity | $6,551.1 | | | $ | (94.2) | | | (2,618.8) | | | $3,838.1 | |
Reorganization Adjustments
(1) Reflects the changes in cash and cash equivalents, as follows:
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Proceeds from issuance of 2L Convertible Notes through the rights offering | $275.0 | |
| Payment of Existing Senior Secured Notes (principal and pre-petition accrued interest) | (308.5) | |
| Payment of Existing Senior Secured Notes commitment fees | (15.5) | |
| Payment of Contingent Cash into escrow | (10.0) | |
| Payment of lender professional and success fees, including deferred financing costs | (31.6) | |
| Net change in cash and cash equivalents | ($90.6) | |
Of the $481.0 million of Successor cash and cash equivalents, $28.3 million was classified as restricted cash. Restricted cash consists of funds held in escrow accounts for the payment of certain professional fees related to the Chapter 11 Cases, pursuant to the Plan.
(2) Reflects the write-off of prepaid expense related to Predecessor directors and officers' insurance policy.
(3) Reflects the net increase to accounts payable and accrued expenses of $10.3 million, representing $16.8 million related to success fees, partially offset by $6.5 million in accrued lender professional fees paid on the Effective Date.
(4) Reflects the reinstatement of short and long-term finance lease liabilities from liabilities subject to compromise.
(5) Reflects the fair value of the Renesas Warrant and the implied value of the obligation to issue New Common Stock to Renesas from the Share Reserve upon obtaining the Regulatory Approvals, or in accordance with the Plan, the obligation to remit cash proceeds to Renesas from the issuance of these shares or exercise of the warrant.
(6) Reflects the changes in other current liabilities including the reinstatement of Short-term operating lease liabilities and supply agreement liabilities from liabilities subject to compromise:
| | | | | |
| As of September 29, 2025 |
| Reinstatement of short-term operating lease liabilities from liabilities subject to compromise | $10.9 | |
| Reinstatement of supply agreements from liabilities subject to compromise | 15.2 | |
| Net change in other current liabilities | $26.1 | |
(7) Reflects the issuance of New Senior Secured Notes and the issuance of New 2L Non-Convertible Notes at fair value, as follows:
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Issuance of New Senior Secured Notes | $1,379.4 | |
| Issuance of New 2L Non-Convertible Notes | 229.6 | |
| Net change in long-term debt | $1,609.0 | |
(8) Reflects the issuance of the New 2L Renesas Convertible Notes at fair value, and the issuance of the New 2L Non-Renesas Convertible Notes (excluding the impact of the equity-classified substantial premium at fair value) as follows:
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Issuance of New 2L Non-Renesas Convertible Notes (principal, including backstop commitment premium) | $331.4 | |
| Issuance of New 2L Renesas Convertible Notes | 216.3 | |
| Issuance cost of New 2L Non-Renesas Convertible Notes | (8.0) | |
| Net change in convertible notes, net | $539.7 | |
(9) Reflects the changes in other long-term liabilities and supply agreement liabilities as follows:
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Reinstatement of long-term operating lease liabilities from liabilities subject to compromise | $154.2 | |
| Reinstatement of long-term supply agreements from liabilities subject to compromise | 44.8 | |
| Change in deferred tax liability as a result of implementation of the plan | 2.5 | |
| Net change in other long-term liabilities | $201.5 | |
(10) Reflects the settlement of liabilities subject to compromise in accordance with the Plan and the resulting gain, as follows:
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Liabilities subject to compromise | $7,315.3 | |
| Reinstatement of short-term finance lease liabilities (see Adjustment 4) | (0.6) | |
| Reinstatement of short-term operating lease liabilities and supply agreements (see Adjustment 6) | (26.1) | |
| Reinstatement of long-term finance lease liabilities (see Adjustment 4) | (8.3) | |
| Reinstatement of long-term operating lease liabilities and supply agreements (see Adjustment 9) | (199.0) | |
| Distribution of proceeds to holders of Senior Secured Notes (see Adjustment 1) | (324.0) | |
| Fair value of issuance of New Senior Secured Notes (see Adjustment 7) | (1,379.4) | |
| Fair Value of Issuance of New 2L Non-Renesas Convertible Notes – principal, including backstop commitment premium (see Adjustment 8) | (331.4) | |
| Fair value issuance of New 2L Non-Renesas Convertible Notes – substantial premium (see Adjustment 12) | (168.8) | |
| Fair value issuance of New 2L Non-Convertible Notes (see Adjustment 7) | (229.6) | |
| Proceeds from the New 2L Non-Renesas Convertible Notes through the rights offering (see Adjustment 1) | 275.0 | |
| Implied value of issuance of Wolfspeed, Inc. New Common Stock, to creditors (see Adjustment 12) | (540.3) | |
| Fair value issuance of New 2L Renesas Convertible Notes (see Adjustment 8) | (216.3) | |
Fair value of the Renesas Warrant (see Adjustment 5) | (33.6) | |
| Implied value of forward equity contract (see Adjustment 5) | (371.1) | |
| Distribution of Contingent Cash to non-consolidated escrow account (see Adjustment 1) | (10.0) | |
| Gain on settlement of liabilities subject to compromise (See Adjustment 13) | $3,751.8 | |
(11) Reflects the cancellation of Old Common Stock and additional paid-in capital.
(12) Reflects the issuance of 25.8 million shares of New Common Stock and additional paid-in capital, as follows:
| | | | | | | | | | | |
| As of September 29, 2025 |
| (in millions of U.S. dollars) | Common Stock | | Additional Paid-in Capital |
| Issuance of Wolfspeed, Inc. common stock, at par, and additional paid-in capital to existing equity holders | $— | | | $28.8 | |
| Issuance of Wolfspeed, Inc. common stock, at par, and additional paid-in capital to holders of convertible notes claims | — | | | 540.3 | |
| Issuance of Additional paid-in capital for equity-classified premium for New 2L Non-Renesas Convertible Notes | — | | | 168.8 | |
| Obligation to issue Contingent Shares to existing equity holders, at the implied value | — | | | 19.2 | |
| Net change in Wolfspeed, Inc. common stock and additional paid-in capital | $— | | | $757.1 | |
(13) Reflects the cumulative impact of the reorganization adjustments discussed above on accumulated deficit.
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Gain on settlement of liabilities subject to compromise | $3,751.8 | |
| Success fees | (33.9) | |
| Write-off related to directors' and officers' insurance policy | (3.6) | |
Cancellation of unvested Predecessor stock compensation awards | (61.5) | |
| Total reorganization adjustments impacting reorganization items, net | 3,652.8 | |
Cancellation of Old Common Stock and additional paid-in capital (direct charge to equity) | $4,165.3 | |
| Issuance of New Common Stock and additional paid-in capital to existing equity holders (direct charge to equity) | (28.8) | |
| Obligation to issue Contingent Shares to existing equity holders (direct charge to equity) | (19.2) | |
| Net deferred tax impacts (classified as tax expense) | (2.5) | |
| Net change in accumulated deficit | $7,767.6 | |
Fresh Start Adjustments
(14) Reflects the fair value adjustment to the Company’s inventories due to the adoption of fresh start accounting. Raw materials were valued based on their replacement cost on the Effective Date; work-in-progress (“WIP”) and finished good were valued based on consideration of inventory value created pre-Effective Date versus post-Effective Date. WIP and finished good methodologies consider the market approach and the cost approach. The values resulting from these methods were reconciled to appropriately allocate profit and expenses in the measurement of the inventory value created prior to the Effective Date.
(15) Reflects the fair value adjustment to the Company’s short-term cloud assets due to the adoption of fresh start accounting. Cloud assets were valued using the indirect method of the cost approach
(16) Reflects the adjustment for the fair value less costs to sell of land held for sale due to the adoption of fresh start accounting. The fair value reflects the expected proceeds from the sale of the land.
(17) Reflects the fair value adjustment to property and equipment due to the adoption of fresh start accounting. Personal property was valued using the indirect method of the cost approach, whereby the reproduction cost for each asset or group of assets is estimated by indexing historical costs recorded in the fixed asset register based on asset type and acquisition date, then adjusted to account for physical deterioration and all forms of obsolescence. Real property (buildings and improvements) was valued using the direct method cost approach, while the sales comparison approach was used to value land and to test the reasonableness of the full property value. Finance lease assets were remeasured at the amount equal to the corresponding finance lease liabilities:
| | | | | | | | |
| (in millions of U.S. dollars) | Amount | Estimated Useful Life (in Years) |
| Land | $14.7 | | n/a |
| Building | (1,195.7) | | 5-40 |
| Machinery and equipment | (537.1) | | 3-10 |
| Leasehold improvements | (91.7) | | Shorter of estimated useful life or lease term |
| Furniture and fixtures | (2.3) | | 5 |
| Computer hardware/software | (35.7) | | 3-10 |
| Vehicles | — | | 5 |
| Tooling | (5.2) | | 3-10 |
| Construction in progress | (1,148.0) | | n/a |
| Finance lease - (see Adjustment 21) | (5.6) | | n/a |
| Total property and equipment, net | ($3,006.6) | | |
(18) Reflects the fair value adjustment to intangible assets, net due to adoption of fresh start accounting. Intangible assets were valued primarily using the income approach. Where applicable, forecasts were allocated to the Power Devices and Materials product lines to separately value intangible assets for each. The following table summarizes the changes in the fair value of identified intangible assets:
| | | | | | | | |
| (in millions of U.S. dollars) | Amount | Estimated Useful Life (in Years) |
| Patent and licensing rights | $33.5 | | 0.5-23 |
| Trade name | 28.0 | | 11 |
| Developed technology | 240.0 | | 5-6 |
| Customer relationships | 120.0 | | 9 |
| Net change in intangible assets | $421.5 | | |
(19) Reflects the changes in other assets due to the adoption of fresh start accounting, as follows:
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Right-of-use ("ROU") assets off-market component | ($6.1) | |
| ROU assets adjustments (see adjustment 22) | (29.0) | |
| Long-term cloud computing assets | (6.9) | |
| Net change in other assets | ($42.0) | |
(20) Reflects the changes in other current liabilities due to the adoption of fresh start accounting, as follows:
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Operating lease liabilities adjustments for incremental borrowing rate ("IBR") (see adjustment 22) | ($5.6) | |
| Off-market long-term purchase agreement | 10.0 | |
| Net change in other current liabilities | $4.4 | |
(21) Reflects the adjustment to the non-current portion of finance lease liabilities due to the adoption of fresh start accounting. Lease liabilities were remeasured using the Company’s IBR at the Effective Date, with a corresponding adjustment to finance lease assets.
(22) Reflects the changes in other long-term liabilities due to the adoption of fresh start accounting, as follows:
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Operating lease liabilities | ($46.4) | |
| Off-market long-term supply agreement | 14.4 | |
| Change in deferred tax liability as a result of fresh start accounting | (1.4) | |
| Net change in other long-term liabilities | ($33.4) | |
Operating lease liabilities were remeasured using the Company’s IBR at the Effective Date, with a corresponding adjustment to ROU assets. Off-market terms identified were attributed to the ROU assets, resulting in a reduction of the ROU assets for unfavorable market terms measured as the present value of the difference between contractual and market-based lease payments over the remaining lease term.
(23) Reflects the cumulative impact of fresh start accounting adjustments discussed above and the elimination of accumulated deficit and accumulated other comprehensive loss.
| | | | | |
| (in millions of U.S. dollars) | As of September 29, 2025 |
| Fresh start adjustment to Inventories, net | ($6.8) | |
| Fresh start adjustment to Prepaid expenses | 0.1 | |
| Fresh start adjustment to Other current assets | (1.6) | |
| Fresh start adjustment to Property and equipment, net | 3,006.6 | |
| Fresh start adjustment to Intangible assets, net | (421.5) | |
| Fresh start adjustment to Other assets | 42.0 | |
| Fresh start adjustment to Other current liabilities | 4.4 | |
| Fresh start adjustment to Finance lease liabilities – long-term | (6.4) | |
| Fresh start adjustment to Other long-term liabilities for operating lease liabilities | (46.4) | |
| Fresh start adjustment to Other long-term liabilities for off-market long-term supply agreement | 14.4 | |
| Reset of accumulated other comprehensive loss – securities-related | 0.6 | |
| Total fresh start adjustments impacting reorganization items, net | 2,585.4 | |
| Reset of accumulated other comprehensive loss - income tax effects | 2.4 | |
| Income tax effects on deferred income taxes | (1.4) | |
| Changes in accumulated deficit | $2,586.4 | |
Note 5 – Discontinued Operations
RF Business Divestiture
On December 2, 2023 (the "RF Closing"), the Company completed the sale of its RF product line (the "RF Business") to MACOM Technology Solutions Holdings, Inc. ("MACOM") pursuant to the terms of the Asset Purchase Agreement (the "RF Purchase Agreement") dated August 22, 2023. Pursuant to the RF Purchase Agreement, the Company received approximately $75 million in cash and 711,528 shares of MACOM common stock (the "MACOM Shares").
In connection with the divestiture of the RF Business (the "RF Business Divestiture"), MACOM assumed operational control of the Company’s 100mm GaN wafer fabrication facility in Research Triangle Park, North Carolina (the "RTP Fab") following the end of fiscal 2025. The transfer of control of the RTP Fab (the "RTP Fab Transfer") was originally delayed to a future date to accommodate the Company’s relocation of certain production equipment currently located in the RTP Fab to its fabrication facility in Durham, North Carolina. Prior to the RTP Fab Transfer, the MACOM Shares were subject to restrictions on transfer and a risk of forfeiture of one-quarter of the MACOM Shares if the RTP Fab Transfer did not occur by the fourth anniversary of the RF Closing. On July 25, 2025, the Company and MACOM completed the RTP Fab Transfer, as contemplated by the RF Purchase Agreement, and MACOM assumed control of the RTP Fab. At such time, the transfer restrictions and risk of forfeiture for the MACOM Shares lapsed and the Master Supply Agreement between the parties (the "RF Master Supply Agreement") terminated pursuant to its terms. Additionally, the Company derecognized assets and liabilities related to the remaining rights and obligations under the RF Master Supply Agreement.
The Company and MACOM also entered into certain ancillary and related agreements, including (i) an Intellectual Property Assignment and License Agreement, which assigned to MACOM certain intellectual property owned by the Company and its affiliates and licensed to MACOM certain additional intellectual property owned by the Company, (ii) a Transition Services Agreement, pursuant to which the Company provides MACOM certain limited transition services following the RF Closing, (iii) a Master Supply Agreement, pursuant to which the Company continued to operate the RTP Fab and supply MACOM with Epi wafers and fabrication services (the "RF Master Supply Agreement") through the date the RTP Fab Transfer is completed (the "RTP Fab Transfer Date"), (iv) a Long-Term Epi Supply Agreement (the "Long-Term Epi Supply Agreement"), pursuant to which MACOM will purchase Epi wafers from the Company from the RTP Fab Transfer Date until the fifth anniversary of the RTP Fab Transfer Date, and (v) an Epi Research and Development Agreement, pursuant to which the Company will provide MACOM certain research and development activities and other technical manufacturing support services related to the RF Business during the period between the RF Closing and expiration of the Long-Term Epi Supply Agreement. In connection with the sale of the property and building of the RTP Fab, an affiliate of MACOM entered into a Lease Agreement with the purchaser of the RTP Fab property and the Company entered into a Sublease Agreement, with the MACOM lessee, under which the Company leased the premises of the RTP Fab until the RTP Fab Transfer Date (except for the portion covered by the real estate license agreement entered into in connection with the RF Business Divestiture, which MACOM retained).
Because the RF Business Divestiture represented a strategic shift that had and will continue to have a major effect on the Company’s operations and financial results, the Company classified the results of the RF Business as discontinued operations in the Company’s consolidated statements of operations for fiscal 2024 and 2023. The Company ceased recording depreciation and amortization of long-lived assets that conveyed in the RF Purchase Agreement upon classification as discontinued operations in August 2023.
The following table presents the financial results of the RF Business as loss from discontinued operations, net of income taxes in the Company's consolidated statements of operations:
| | | | | | | | | |
| | | | | Predecessor |
| | | | | Fiscal Year Ended |
| (in millions of U.S. Dollars) | | | | | June 30, 2024 |
| Revenue, net | | | | | $59.6 | |
| Cost of revenue, net | | | | | 68.7 | |
| Gross (loss) profit | | | | | (9.1) | |
| Operating expenses: | | | | | |
| Research and development | | | | | 30.5 | |
| Sales, general and administrative | | | | | 13.9 | |
| Amortization of intangibles | | | | | 1.5 | |
| Loss on disposal of assets | | | | | 0.3 | |
| | | | | |
| Other operating expense | | | | | 24.3 | |
| Operating loss | | | | | (79.6) | |
| Non-operating expense | | | | | — | |
| Loss before income taxes and loss on sale | | | | | (79.6) | |
| Loss on sale | | | | | 204.0 | |
| Loss before income taxes | | | | | (283.6) | |
| Income tax expense | | | | | 7.0 | |
| Net loss | | | | | ($290.6) | |
| | | | | |
| | | | | |
During fiscal 2024, the Company recorded a total loss on sale of $204.0 million, which was net against the impairments and excess loss liability on assets held for sale. The total cost of selling the RF Business was $25.4 million, of which $12.2 million was recognized in fiscal 2024.
At the inception of the RF Master Supply Agreement, the Company recorded a supply agreement liability of $95.0 million, of which $0.0 million and $25.4 million was outstanding as of June 28, 2026 and June 29, 2025, respectively. The supply agreement liability is recognized in other current liabilities on the consolidated balance sheet as of June 29, 2025. A receivable of $0.0 million and $5.3 million in connection with the RF Master Supply Agreement is included in other current assets on the consolidated balance sheet as of June 28, 2026 and June 29, 2025, respectively.
In connection with the divestiture of the RF Business (the "RF Business Divestiture"), MACOM was entitled to assume control of the Company’s 100mm gallium nitride ("GaN") wafer fabrication facility in Research Triangle Park, North Carolina (the "RTP Fab") approximately two years following the RF Closing (the "RTP Fab Transfer"). On July 25, 2025, the Company and MACOM completed the RTP Fab Transfer, as contemplated by the RF Purchase Agreement, and MACOM assumed control of the RTP Fab. At such time, the transfer restrictions and risk of forfeiture for the MACOM Shares lapsed and the Master Supply Agreement between the parties (the "RF Master Supply Agreement") terminated pursuant to its terms. Additionally, the Company derecognized assets and liabilities related to the remaining rights and obligations under the RF Master Supply Agreement. In connection with the RTP Fab Transfer, the Company recognized a gain of $25.4 million within "Non-operating income, net" during the period from June 30, 2025 to September 29, 2025. In connection with the RTP Fab Transfer, the Long-Term Epi Supply Agreement between the parties commenced. At the time of the divestiture, the Company recorded a liability for the Long-term EPI Supply Agreement of $58.0 million, which remeasured to $72.4 million upon the adoption of fresh start accounting. The amounts outstanding under the Long-term Epi Supply Agreement were $59.6 million and $58.0 million as of June 28, 2026 and June 29, 2025, respectively. The decrease in the balance of the liability was recognized as revenue in the Consolidated Statement of Operations. The supply agreement liability is recognized in Other Current Liabilities and Other Long-term Liabilities as of June 28, 2026, and Other Current Liabilities and Other Long-term Liabilities on the consolidated balance sheet as of June 29, 2025, respectively.
On September 8, 2025, the Company completed the sale of the MACOM Shares received in connection with the sale of the RF Business for $91.1 million, net of transaction costs, of which approximately $30.3 million was distributed to holders of the existing Senior Secured Notes upon emergence from the Chapter 11 Cases.
LED Business Divestiture
On March 1, 2021, the Company completed the sale of certain assets and subsidiaries comprising its former LED Products segment to SMART Global Holdings, Inc. ("SGH") and its wholly owned subsidiary CreeLED, Inc. ("CreeLED", and collectively with SGH, "SMART") (the "LED Business Divestiture") pursuant to the terms of the Asset Purchase Agreement (the "LED Purchase Agreement"), dated October 18, 2020, as amended.
In connection with the closing of the LED Business Divestiture, the Company and CreeLED also entered into certain ancillary and related agreements, including a Wafer Supply and Fabrication Services Agreement (the "Wafer Supply Agreement"), pursuant to which the Company supplied CreeLED with certain silicon carbide materials and fabrication services. The Company terminated the Wafer Supply Agreement effective as of September 30, 2024. The Company recognized a net loss of $0.0 million, $0.0 million, $9.2 million and $25.3 million in non-operating income, net for the periods from June 30, 2025 to September 29, 2025 and September 30, 2025 to June 28, 2026 and the fiscal years ended June 29, 2025 and June 30, 2024, respectively, related to the Wafer Supply Agreement.
Note 6 – Revenue Recognition
Contract liabilities and distributor-related reserves were $65.4 million and $65.6 million as of June 28, 2026 and June 29, 2025, respectively. The decrease was primarily due to a decrease in customer reserve deposits, partially offset by an increase in distributor-related reserves. Contract liabilities and distributor-related reserves are recorded within contract liabilities and distributor-related reserves and other long-term liabilities on the consolidated balance sheets.
Practical Expedients and Exemptions
The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.
Incidental contract costs that are not material in context of the delivery of products are expensed as incurred. Sales commissions are expensed when the amortization period is less than one year. Contract assets, such as costs to obtain or fulfill contracts, are an insignificant component of the Company’s revenue recognition process. The majority of the Company’s fulfillment costs as a manufacturer consist of inventory, fixed assets, and intangible assets, all of which are accounted for under the respective guidance for those asset types.
The Company’s accounts receivable balance represents the Company’s unconditional right to receive consideration from its customers with contracts. Payments are typically due within 30 days of completion of the performance obligation and invoicing and therefore do not contain significant financing components.
Sales tax, value-added tax, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue, and shipping and handling costs are treated as fulfillment activities and are included in cost of revenue in the Company’s consolidated statements of operations.
For the periods from June 30, 2025 to September 29, 2025 and from September 30, 2025 to June 28, 2026, the Company recognized $1.2 million and $5.7 million, respectively, in revenue from contract liability balances. For the fiscal year ended June 29, 2025, the Company recognized $1.2 million in revenue from contract liability balances, and for the fiscal year ended June 30, 2024, the Company did not recognize any material revenue from contract liability balances.
Product Line Revenue
The Company sells products from within two product lines: Power Products and Materials Products. Revenue from these two product lines is as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended | | Fiscal Year Ended |
| (in millions of U.S. Dollars) | | | June 29, 2025 | | June 30, 2024 |
| Power Products | $324.7 | | | $131.8 | | | $414.0 | | | $415.6 | |
| Materials Products | 143.6 | | | 65.0 | | | 343.6 | | | 391.6 | |
| Total | $468.3 | | | $196.8 | | | $757.6 | | | $807.2 | |
Geographic Information
The Company conducts business in several geographic areas. Revenue is attributed to a particular geographic region based on the shipping address for the products. Disaggregated revenue from external customers by geographic area is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | For the Fiscal Year Ended | | For the Fiscal Year Ended |
| | | June 29, 2025 | | June 30, 2024 |
| (in millions of U.S. Dollars) | Revenue | | % | | Revenue | | % | | Revenue | | % | | Revenue | | % |
| United States | $160.4 | | | 34.3 | % | | $44.9 | | | 22.8 | % | | $135.5 | | | 17.9 | % | | $115.0 | | | 14.2 | % |
| Hong Kong | 88.8 | | | 19.0 | % | | 26.1 | | | 13.3 | % | | 99.0 | | | 13.1 | % | | 116.4 | | | 14.4 | % |
| Europe | 79.2 | | | 16.9 | % | | 36.3 | | | 18.4 | % | | 151.3 | | | 20.0 | % | | 295.2 | | | 36.6 | % |
Asia Pacific(1) | 79.2 | | 16.9 | % | | 49.1 | | 24.9 | % | | 104.2 | | 13.8 | % | | 72.6 | | 9.0 | % |
| Singapore | 23.0 | | | 4.9 | % | | 7.6 | | | 3.9 | % | | 104.1 | | | 13.7 | % | | 101.6 | | | 12.6 | % |
| Japan | 18.4 | | | 3.9 | % | | 13.3 | | | 6.8 | % | | 91.1 | | | 12.0 | % | | 63.2 | | | 7.8 | % |
| China | 14.7 | | | 3.1 | % | | 17.9 | | | 9.1 | % | | 70.2 | | | 9.3 | % | | 41.5 | | | 5.1 | % |
| Other | 4.6 | | | 1.0 | % | | 1.6 | | | 0.8 | % | | 2.2 | | | 0.3 | % | | 1.7 | | | 0.3 | % |
| Total | $468.3 | | | | | $196.8 | | | | | $757.6 | | | | | $807.2 | | | |
| (1) Excluding China, Hong Kong, Japan and Singapore. |
Note 7 – Leases
The Company primarily leases manufacturing and office spaces and bulk gas equipment. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. Variable costs include lease payments that are volume or usage-driven in accordance with the use of the underlying asset, as well as non-lease components incurred with respect to actual terms rather than contractually fixed amounts. For details on the Company's lease policies, see the significant accounting policy disclosures in Note 2, “Basis of Presentation and Summary of Significant Accounting Policies."
The Company's finance lease obligations primarily relate to contract manufacturing space in Malaysia and a 49-year ground lease on the Company's silicon carbide device fabrication facility in New York.
Balance Sheet
Lease assets and liabilities and the corresponding balance sheet classifications are as follows:
| | | | | | | | | | | |
| (in millions of U.S. Dollars) | Successor | | Predecessor |
| Operating Leases: | June 28, 2026 | | June 29, 2025 |
Right-of-use assets (1) | $96.8 | | | $123.1 | |
| | | |
Current lease liability (2) | 7.4 | | | 9.9 | |
Non-current lease liability (3) | 99.2 | | | 139.5 | |
| Total operating lease liabilities | $106.6 | | | $149.4 | |
| | | |
| Finance Leases: | | | |
Finance lease assets (4) | $2.1 | | | $8.3 | |
| | | |
| Current portion of finance lease liabilities | 0.2 | | | 0.5 | |
| Finance lease liabilities, less current portion | 1.9 | | | 8.4 | |
| Total finance lease liabilities | $2.1 | | | $8.9 | |
(1) Within other assets on the consolidated balance sheets.
(2) Within other current liabilities on the consolidated balance sheets.
(3) Within other long-term liabilities on the consolidated balance sheets.
(4) Within property and equipment, net on the consolidated balance sheets.
Statement of Operations
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Operating lease expense | $15.0 | | | $4.3 | | | $16.7 | | | $13.9 | |
| Finance lease amortization | 0.3 | | | 0.2 | | | 0.8 | | | 0.8 | |
Interest expense for finance leases was immaterial for all periods presented.
Cash Flows
Cash flow information consisted of the following (1):
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Cash (used in) provided by operating activities: | | | | | | | |
| Cash paid for operating leases | ($15.6) | | | ($4.1) | | | ($15.5) | | | ($12.6) | |
| Cash received for tenant allowance on operating leases | — | | | — | | | 1.8 | | | 0.4 | |
| Cash paid for interest portion of financing leases | (0.2) | | | (0.1) | | | (0.2) | | | (0.3) | |
| Cash used in financing activities: | | | | | | | |
| Cash paid for principal portion of finance leases | (0.4) | | | (0.1) | | | (0.5) | | | (0.4) | |
(1) See "Statements of Cash Flows - non-cash activities" in Note 2, "Basis of Presentation and Summary of Significant Accounting Policies," for non-cash activities related to leases.
Lease Liability Maturities
Maturities of operating and finance lease liabilities as of June 28, 2026 were as follows:
| | | | | | | | | | | |
| (in millions of U.S. Dollars) | Successor |
| Fiscal Year Ending | Operating Leases | Finance Leases | Total |
| June 27, 2027 | $19.2 | | $0.4 | | $19.6 | |
| June 25, 2028 | 18.1 | | 0.3 | | 18.4 | |
| June 24, 2029 | 17.3 | | 0.3 | | 17.6 | |
| June 30, 2030 | 16.0 | | 0.2 | | 16.2 | |
| June 29, 2031 | 15.5 | | 0.3 | | 15.8 | |
| Thereafter | 115.1 | | 13.3 | | 128.4 | |
| Total lease payments | 201.2 | | 14.8 | | 216.0 | |
| Future tenant improvement allowances | — | | — | | — | |
| Imputed lease interest | (94.6) | | (12.7) | | (107.3) | |
| Total lease liabilities | $106.6 | | $2.1 | | $108.7 | |
Supplemental Disclosures | | | | | | | | |
| Successor |
| Operating Leases | Finance Leases |
Weighted average remaining lease term (in months) (1) | 142 | 452 |
Weighted average discount rate (2) | 11.77 | % | 13.84 | % |
(1) Weighted average remaining lease term of finance leases without the 49-year ground lease is 19 months.
(2) Weighted average discount rate of finance leases without the 49-year ground lease is 10.18%.
Lease Impairment
For the fiscal year ended June 29, 2025, the Company recorded $4.8 million of non-cash impairment charges for the abandonment of ROU assets as a result of the ongoing factory consolidation and optimization initiatives. The impairment of the ROU assets is included in "restructuring and other expenses" within the accompanying consolidated statement of operations. Refer to Note 18 - "Restructuring" for additional details.
Note 8 – Investments
Investments consist of municipal bonds, corporate bonds, U.S. agency securities, commercial paper and certificates of deposit. All short-term investments are classified as available-for-sale.
Short-term investments as of June 28, 2026 consist of the following:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Successor |
| June 28, 2026 |
| (in millions of U.S. Dollars) | Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Credit Loss Allowance | | Estimated Fair Value |
| Corporate bonds | $210.3 | | | $— | | | ($0.4) | | | $— | | | $209.9 | |
| U.S. treasury securities | 185.3 | | | — | | | (0.2) | | | — | | | 185.1 | |
| Municipal bonds | 86.6 | | | 0.1 | | | (0.1) | | | — | | | 86.6 | |
| Certificates of deposit | 20.2 | | | — | | | — | | | — | | | 20.2 | |
| | | | | | | | | |
| | | | | | | | | |
| Commercial paper | 10.5 | | | — | | | — | | | — | | | 10.5 | |
| | | | | | | | | |
| | | | | | | | | |
| Total short-term investments | $512.9 | | | $0.1 | | | ($0.7) | | | $— | | | $512.3 | |
The following table presents the gross unrealized losses and estimated fair value of the Company’s short-term investments, aggregated by investment type and the length of time that individual securities have been in a continuous unrealized loss position:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Successor |
| June 28, 2026 |
| Less than 12 Months | | Greater than 12 Months | | Total |
| (in millions of U.S. Dollars) | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss |
| Corporate bonds | $155.7 | | | ($0.4) | | | $11.2 | | | $— | | | $166.9 | | | ($0.4) | |
| U.S. treasury securities | 129.0 | | | (0.1) | | | 29.7 | | | (0.1) | | | 158.7 | | | (0.2) | |
| Municipal bonds | 68.0 | | | (0.1) | | | 2.6 | | | — | | | 70.6 | | | (0.1) | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Total | $352.7 | | | ($0.6) | | | $43.5 | | | ($0.1) | | | $396.2 | | | ($0.7) | |
| Number of securities with an unrealized loss | | | 173 | | | | | 12 | | | | | 185 | |
Short-term investments as of June 29, 2025 consist of the following:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Predecessor |
| June 29, 2025 |
| (in millions of U.S. Dollars) | Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Credit Loss Allowance | | Estimated Fair Value |
| U.S. treasury securities | $ | 192.0 | | | $ | 0.1 | | | $ | — | | | $ | — | | | $ | 192.1 | |
| Corporate bonds | 196.8 | | | 0.3 | | | (1.5) | | | — | | | 195.6 | |
| Municipal bonds | 79.5 | | | 0.2 | | | (0.5) | | | — | | | 79.2 | |
| Certificates of deposit | 5.0 | | | — | | | — | | | — | | | 5.0 | |
| Commercial paper | 16.3 | | | — | | | — | | | — | | | 16.3 | |
| | | | | | | | | |
| Total short-term investments | $ | 489.6 | | | $ | 0.6 | | | $ | (2.0) | | | $ | — | | | $ | 488.2 | |
The following table presents the gross unrealized losses and estimated fair value of the Company’s short-term investments, aggregated by investment type and the length of time that individual securities have been in a continuous unrealized loss position:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Predecessor |
| June 29, 2025 |
| Less than 12 Months | | Greater than 12 Months | | Total |
| (in millions of U.S. Dollars) | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss |
| Corporate bonds | $28.7 | | | $— | | | $65.2 | | | ($1.5) | | | $93.9 | | | ($1.5) | |
| Municipal bonds | 6.2 | | | — | | | 41.3 | | | (0.5) | | | 47.5 | | | (0.5) | |
| U.S. treasury securities | 90.6 | | | — | | | — | | | — | | | 90.6 | | | — | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Total | $125.5 | | | $— | | | $106.5 | | | ($2.0) | | | $232.0 | | | ($2.0) | |
| Number of securities with an unrealized loss | | | 54 | | | | | 25 | | | | | 79 | |
Additionally, the Company held seven cash equivalent securities with an aggregate fair value of $37.9 million in unrealized loss positions as of June 28, 2026. The aggregate unrealized loss was less than $0.1 million.
The Company does not include accrued interest in estimated fair values of short-term investments and does not record an allowance for credit losses on receivables related to accrued interest. Accrued interest receivable was $4.8 million and $5.4 million as of June 28, 2026 and June 29, 2025, respectively, and is recorded in other current assets on the consolidated balance sheets. When necessary, write-offs of noncollectible interest income are recorded as a reversal to interest income. There were no write-offs of noncollectible interest income for the period from June 30, 2025 to September 29, 2025 and September 30, 2025 to June 28, 2026, June 29, 2025 or June 30, 2024.
The Company evaluates its investments for expected credit losses. The Company believes it is able to and intends to hold each of the investments held with an unrealized loss as of June 28, 2026 until the investments fully recover in market value. No allowance for credit losses was recorded for the period from June 30, 2025 to September 29, 2025 and September 30, 2025 to June 28, 2026, June 29, 2025 or June 30, 2024.
The contractual maturities of short-term investments at June 28, 2026 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Successor |
| (in millions of U.S. Dollars) | Within One Year | | After One, Within Five Years | | After Five, Within Ten Years | | After Ten Years | | Total |
| Corporate bonds | $180.5 | | | $29.4 | | | $— | | | $— | | | $209.9 | |
| U.S. treasury securities | 144.0 | | | 41.1 | | | — | | | — | | | 185.1 | |
| Municipal bonds | 78.7 | | | 7.9 | | | — | | | — | | | 86.6 | |
| Certificates of deposit | 20.0 | | | 0.2 | | | — | | | — | | | 20.2 | |
| | | | | | | | | |
| | | | | | | | | |
| Commercial paper | 10.5 | | | — | | | — | | | — | | | 10.5 | |
| | | | | | | | | |
| | | | | | | | | |
| Total short-term investments | $433.7 | | | $78.6 | | | $— | | | $— | | | $512.3 | |
Note 9 – Fair Value of Financial Instruments
Under U.S. GAAP, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses various valuation approaches, including quoted market prices and discounted cash flows. U.S. GAAP also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions regarding what a third party would use in pricing an asset or liability. The fair value hierarchy is categorized into three levels based on the reliability of inputs as follows:
•Level 1 - Valuations based on quoted prices in active markets for identical instruments that the Company is able to access. Because valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
•Level 2 - Valuations based on quoted prices in active markets for instruments that are similar or quoted prices in markets that are not active for identical or similar instruments, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.
•Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
The Company did not have any financial assets requiring the use of Level 3 inputs as of June 28, 2026. There were no transfers between Level 1 and Level 2 during the fiscal year ended June 28, 2026.
Financial instruments carried at fair value were as follows:
| | | | | | | | | | | | | | | | | | | | | | |
| Estimated fair value | | | | | | | | |
| | Successor | | Predecessor | | | | | | | | |
| (in millions of U.S. Dollars) | Fair value hierarchy | June 28, 2026 | | June 29, 2025 | | | | | | | | |
| Assets: | | | | | | | | | | | | |
| Money market funds | 1 | $63.5 | | | $61.8 | | | | | | | | | |
| U.S. treasury securities | 1 | 220.9 | | | 224.6 | | | | | | | | | |
| MACOM Shares | 1 | — | | | 102.0 | | | | | | | | | |
| Municipal bonds | 2 | 89.0 | | | 79.2 | | | | | | | | | |
| Corporate bonds | 2 | 209.9 | | | 196.8 | | | | | | | | | |
| | | | | | | | | | | | |
| Commercial paper | 2 | 43.4 | | | 28.3 | | | | | | | | | |
| Certificates of deposit | 2 | $20.2 | | | $5.0 | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
As of June 29, 2025, other current assets consisted of the MACOM Shares which the Company received as partial consideration in connection with the RF Business Divestiture. These shares were remeasured to fair value each period with changes in the fair value of the shares recognized in non-operating income, net. In the first quarter of fiscal 2026, the Company sold the MACOM shares
Forward Equity Contract
The fair value of the forward equity contract is determined using the observable market prices of our common stock and is not adjusted for holding restrictions. With all Regulatory Approvals obtained in January 2026, and the shares being delivered, the forward equity contract was extinguished as of June 28, 2026, after being remeasured at fair value date as of the date on which the Regulatory Approvals were received, with changes in fair value recognized as a gain of $79.1 million in "Non-operating income, net" in the Consolidated Statements of Operations.
Embedded Derivative
The New 2L Renesas Convertible Notes contain embedded conversion features that provide for conversion into shares of common stock as defined in the agreements after receipt of the Regulatory Approvals. Before the Regulatory Approvals were obtained, the conversion feature could only be cash settled as the notes would not be convertible into common stock; the cash settled equity-indexed feature did not qualify for a scope exception under ASC 815. Accordingly, this feature was required to be bifurcated and accounted for separately as an embedded derivative. The embedded derivative liability was initially recorded at fair value at the issuance date, with an offsetting discount recorded to the host debt instrument. The discount was amortized to interest expense over the term of the notes using the effective interest method. The embedded derivative was subsequently remeasured at fair value at each reporting date, and most recently as of the date on which the Regulatory Approvals were received, with changes in fair value recognized in “Non-operating income, net" in the Consolidated Statements of Operations. The fair value of the embedded derivatives was determined using the Goldman Sachs binomial lattice model and was classified within Level 3 of the fair value hierarchy because the valuation model involves the use of unobservable inputs relating to the Company’s estimate of its expected stock volatility which was developed based on the historical volatility of a publicly traded set of peer companies. The expected volatility inputs utilized for the fair value measurements of the embedded derivatives upon the Effective Date and as of the date on which the Regulatory Approvals were received was 60.0%.
Upon receipt of the Regulatory Approvals in January 2026, the embedded derivative met the equity classification criteria under ASC 815 and ASC 480. Accordingly, the Company reclassified the embedded derivative from liabilities to additional paid‑in capital at its fair value as of the reclassification date of $87.9 million. The reclassification did not result in the recognition of a gain or loss in the statement of operations. Subsequent to the January 2026 reclassification, the embedded derivative is no longer subject to fair value remeasurement.
Stock Warrant Liability
Prior to the receipt of the Regulatory Approvals, the stock warrants held by Renesas could only be settled for cash such that they were accounted for as derivative liabilities under ASC 815. The warrants were subsequently remeasured at fair value as of the date on which the Regulatory Approvals were received, with changes in fair value recognized in "Non-operating income, net" in the Consolidated Statements of Operation. The fair value of the warrant liability was determined using a Black-Scholes model and was classified within Level 3 of the fair value hierarchy. The stock warrant liability was classified as a Level 3 measurement within the fair value hierarchy because the valuation models involve the use of unobservable inputs relating to the Company’s estimate of its expected stock volatility which was developed based on the historical volatility of a publicly traded set of peer companies. The expected volatility inputs utilized for the fair value measurements of the Stock Warrant upon the Effective Date and as of the date on which the Regulatory Approvals were received, was 70.0%.
Upon receipt of the Regulatory Approvals in January 2026, the Company reclassified its stock warrant liability to equity following the receipt of all required regulatory approvals. Upon reclassification, the stock warrant liability was no longer subject to fair value remeasurement. Refer to Note 3 "Emergence from Voluntary Reorganization under Chapter 11" for more information.
Level 3 Rollforward
The following is a rollforward of balances for liabilities classified as recurring Level 3 fair value measurements:
| | | | | | | | | | | |
| (in millions of U.S. Dollars) | Stock Warrant Liability | | Embedded Derivative |
| Balance as of June 29, 2025 (Predecessor) | $— | | | $— | |
| Issuance at September 29, 2025 (See Note 3 and Note 4) | $33.6 | | $94.5 |
Changes in fair value | (2.1) | | (6.6) |
| | | |
| Reclassification to equity | (31.5) | | (87.9) |
| Balance as of June 28, 2026 | $— | | $— |
Please refer to Note 3, "Emergence from Voluntary Reorganization Under Chapter 11," and Note 4, "Fresh Start Accounting," for additional information on the forward equity contracts, and the stock warrant liability.
Note 10 – Intangible Assets
Intangible assets, net included the following:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| June 28, 2026 | | June 29, 2025 |
| (in millions of U.S. Dollars) | Gross | | Accumulated Amortization | | Net | | Gross | | Accumulated Amortization | | Net |
| Intangible assets: | | | | | | | | | | | |
| Customer relationships | $120.0 | | | ($10.0) | | | $110.0 | | | $— | | | $— | | | $— | |
| Developed technology | 240.0 | | | (31.3) | | | 208.7 | | | — | | | — | | | — | |
| | | | | | | | | | | |
| Trade name | 28.0 | | | (1.9) | | | 26.1 | | | — | | | — | | | — | |
| Finite-lived intangible assets | 388.0 | | | (43.2) | | | 344.8 | | | — | | | — | | | — | |
| Patent and licensing rights | 60.9 | | | (13.5) | | | 47.4 | | | 50.5 | | | (26.7) | | | 23.8 | |
| Total intangible assets | $448.9 | | | ($56.7) | | | $392.2 | | | $50.5 | | | ($26.7) | | | $23.8 | |
Total amortization of finite-lived intangible assets was $0.0 million, $43.2 million, $1.2 million and $1.1 million and total amortization of patents and licensing rights was $1.0 million, $14.2 million, $4.2 million and $4.4 million for the periods from June 30, 2025 to September 29, 2025, and September 30, 2025 to June 28, 2026 and the years ended June 29, 2025 and June 30, 2024, respectively.
The Company invested $1.4 million, $3.6 million, $5.3 million and $5.9 million for the periods from June 30, 2025 to September 29, 2025, and September 30, 2025 to June 28, 2026 and the years ended June 29, 2025 and June 30, 2024, respectively, for patent and licensing rights.
Customer relationships, developed technology, trade name, and patent and licensing rights had weighted-average remaining useful lives of 8.3 years, 5.0 years, 10.3 years, and 7.9 years, respectively, as of June 28, 2026. Total future amortization expense for each of the five succeeding fiscal years for definite-lived intangible assets is estimated to be as follows:
| | | | | | | | | | | | | |
(in millions of U.S. Dollars)
Fiscal Year Ending | | | | | | | | | Total |
| June 27, 2027 | | | | | | | | | $68.5 | |
| June 25, 2028 | | | | | | | | | 65.3 | |
| June 24, 2029 | | | | | | | | | 63.8 | |
| June 30, 2030 | | | | | | | | | 62.2 | |
| June 29, 2031 | | | | | | | | | 61.6 | |
| Thereafter | | | | | | | | | 70.8 | |
| Total future amortization expense | | | | | | | | | $392.2 | |
Note 11 – Debt
As of June 29, 2025 (Predecessor):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions of U.S. Dollars) | Maturity Date | Effective Interest Rate | Initial Principal | Repayment of principal | Conversion to common stock | Outstanding principal | Unamortized premium/discount | Ending Balance | Equity component | Fair Value | Fair value level |
1.75% Convertible Notes | 5/1/2026 | 2.2 | % | $575.0 | | $— | | $— | | $575.0 | | ($2.0) | | $573.0 | | $— | | $145.2 | | Level 2 |
0.25% Convertible Notes | 2/15/2028 | 0.6 | % | 750.0 | | — | | — | | 750.0 | | (7.9) | | $742.1 | | — | | 185.6 | | Level 2 |
1.875% Convertible Notes | 12/1/2029 | 2.1 | % | 1,750.0 | | — | | — | | 1,750.0 | | (20.7) | | $1,729.3 | | — | | 450.6 | | Level 2 |
| 2030 Senior Notes | 6/23/2030 | 16.3 | % | 1,250.0 | | — | | — | | 1,521.2 | | (52.3) | | $1,468.9 | | — | | 1,308.2 | | Level 2 |
| CRD Agreement Deposits | 7/5/2033 | 6.8 | % | 2,000.0 | | — | | — | | 2,062.0 | | (37.3) | | $2,024.7 | | — | | 556.7 | | Level 3 |
| | | $6,325.0 | | $— | | $— | | $6,658.2 | | ($120.2) | | $6,538.0 | | $— | | $2,646.3 | | |
On the Petition Date, the Company commenced the Chapter 11 Cases. The filing of the Chapter 11 Cases constituted an event of default that accelerated the obligations under the Convertible Notes, Existing Senior Secured Notes, and the unsecured Customer Refundable Deposit Agreement, dated as of July 5, 2023, with Renesas (as amended to date, the “CRD Agreement”). On the Effective Date, the Company emerged from the Chapter 11 Cases.
As of June 28, 2026 (Successor)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions of U.S. Dollars) | Maturity Date(1) | Effective Interest Rate | Initial Principal | Repayment of principal(2) | Conversion to common stock(3) | Outstanding principal | Unamortized premium/discount | | Ending Balance | Equity component | Fair Value | Fair value level |
| New Senior Secured Notes | 6/23/2030 | 12.9% | $1,259.2 | | ($623.3) | | $— | | $635.9 | | $59.2 | | | $695.1 | | $— | | $705.7 | | Level 2 |
| New 2L Non-Convertible Notes | 6/15/2031 | 12.5% | 296.4 | | — | | — | | $296.4 | | (60.5) | | | $235.9 | | — | | 269.0 | | Level 2 |
New 2L Non-Renesas Convertible Notes(4) | 6/15/2031 | 3.0% | 331.4 | | — | | (64.3) | | $267.1 | | (5.6) | | | $261.5 | | 136.1 | | 1,059.5 | | Level 2 |
New 2L Renesas Convertible Notes(5) | 6/15/2031 | 12.3% | 203.6 | | — | | — | | $203.6 | | (74.0) | | | $129.6 | | 87.9 | | 517.8 | Level 3 |
1.5L Convertible Notes(6) | 3/15/2031 | 4.3% | 379.0 | | — | | — | | $379.0 | | (13.6) | | | $365.4 | | — | | 913.8 | Level 2 |
| | | $2,469.6 | | ($623.3) | | ($64.3) | | $1,782.0 | | ($94.5) | | | $1,687.5 | | $224.0 | | $3,465.8 | | |
(1)Each instrument is as defined in the Plan.
(2)On December 22, 2025, the Company repurchased $175.0 million of aggregate principal of the New Senior Secured Notes, plus accrued and unpaid interest at a purchase price of $197.9 million. On December 23, 2025, $10.2 million of Paid-in-Kind ("PIK") Interest was incurred and recorded to the outstanding New Senior Secured Notes principal amount. On March 23, 2026, $10.9 million of PIK interest was incurred and recorded to the outstanding New Senior Secured Notes principal amount. On March 26, 2026, the Company used all of the aggregate gross proceeds from the 1.5L Convertible Notes (as defined below) and the Securities Purchase Agreement (as defined below) (refer to Note 12 - "Stockholders' Equity and Pre-funded Warrants" for additional information) to redeem $475.9 million of the outstanding New Senior Secured Notes at a purchase price of $524.3 million. On June 23, 2026, $6.4 million of PIK interest was incurred and recorded to the outstanding New Senior Secured Notes principal amount.
(3)On September 29, 2025, the Company issued the New 2L Non-Renesas Convertible Notes and New 2L Renesas Convertible Notes. The notes bear interest at 2.5% per annum on the outstanding principal, are secured, and are convertible into shares of common stock at a conversion price of $12.23 and $18.35 per share, respectively. As of June 28, 2026, $64.3 million of New 2L Non-Renesas Convertible Notes were converted into 5.3 million shares of common stock.
(4)ASC Topic 470: Debt (“ASC 470”) presumes that when a convertible debt instrument is issued at a substantial premium compared to the principal amount, the premium should be recognized in equity as paid-in-capital. The excess of the initial carrying amount over par of $168.8 million was recorded to additional paid-in-capital. Approximately 19.4% of the equity component is not related to the outstanding convertible notes due to conversions during the period from September 30, 2025 to June 28, 2026.
(5)During the Successor period ended June 28, 2026, the Company reclassified the derivative liability to equity of $87.9 million (refer to Note 9 - "Fair Value of Financial Instruments" for additional information).
(6)On March 26, 2026, the Company issued the 1.5 Convertible Notes (as defined below). The notes bear interest at 3.5% per annum on the outstanding principal, are secured, and are convertible into shares of common stock at an initial conversion price of approximately $20.14 per share.
On the Effective Date, the conditions to the effectiveness of the Plan were satisfied or waived and the Plan became effective, and each holder of the aforementioned corporate debt holdings as of the Effective Date and deposits under the CRD Agreement
received portions of the restated debt obligations and New Common Stock, and all of the Company’s outstanding obligations under the aforementioned corporate debt holdings as of the Effective Date and CRD Agreement were discharged and terminated. Please refer to Note 2, "Basis of Presentation and Summary of Significant Accounting Policies," and Note 3, "Emergence from Voluntary Reorganization under Chapter 11," for additional information on the debt.
As of June 28, 2026, the Company was in compliance with all covenants relating to the New Senior Secured Notes, New 2L Non-Convertible Notes, New 2L Non-Renesas Convertible Notes, New 2L Renesas Convertible Notes, and the 1.5L Convertible Notes.
New 1.5L Convertible Notes
On March 26, 2026, the Company entered into the 3.5% Convertible 1.5 Lien Senior Secured Notes due 2031 (the "1.5L Convertible Notes") in a private placement (the "Notes Placement") with an aggregate principal balance of $379.0 million. The 1.5L Convertible Notes were issued pursuant to, and are governed by, an indenture (the “1.5L Convertible Notes Indenture”), dated as of March 26, 2026, among the Company, Wolfspeed Texas, as Subsidiary Guarantor, and U.S. Bank Trust Company, National Association, as Trustee and Collateral Agent.
The 1.5L Convertible Notes are guaranteed on a senior basis by the Guarantor, and the 1.5L Convertible Notes and the related guarantee by the Subsidiary Guarantor are senior, secured obligations of the Company and the Subsidiary Guarantor, secured by substantially all assets of the Company and the Subsidiary Guarantor (the “Collateral”). The 1.5L Convertible Notes and related guarantee are effectively subordinated to all secured indebtedness of the Company and the Subsidiary Guarantor that is secured by a lien on the Collateral that is senior or prior to the lien on the Collateral securing the 1.5L Convertible Notes (including obligations under the Company’s New Senior Secured Notes) and are effectively senior to all indebtedness of the Company and the Subsidiary Guarantor that is not secured by a lien on the Collateral, or that is secured by a lien ranking junior to the lien on the Collateral securing the 1.5L Convertible Notes (including the Company’s New 2L Non-Renesas Convertible Notes and New 2L Non-Convertible Notes).
The 1.5L Convertible Notes bear cash interest at a rate of 3.5% per year. Interest is payable semi-annually in arrears on March 15 and September 15 of each year, commencing on September 15, 2026. The 1.5L Convertible Notes mature on March 15, 2031, unless earlier repurchased, redeemed or converted.
The 1.5L Convertible Notes are convertible at the option of the holders at any time (subject to certain limitations) until the close of business on the second scheduled trading day immediately before the maturity date. The initial conversion rate for the 1.5L Convertible Notes is 49.6623 shares of the New Common Stock, per $1,000 principal amount of the 1.5L Convertible Notes (which is equivalent to an initial conversion price of approximately $20.14 per share of New Common Stock, which represents a conversion premium of approximately 20.0% over the last reported sale price of $16.78 per share of New Common Stock on the New York Stock Exchange on March 18, 2026). The conversion rate is subject to customary anti-dilution adjustments. Holders of the 1.5L Convertible Notes will be entitled to make-whole adjustments to the conversion rates in the event of a change of control or an optional redemption as described below. Upon conversion, the 1.5L Convertible Notes may be settled in cash, shares of New Common Stock or a combination thereof, at the Company’s election.
Upon the occurrence of a “Fundamental Change” (as defined below), subject to certain exceptions, holders may require the Company to repurchase all or a portion of their 1.5L Convertible Notes for cash at a price equal to 100% of the principal amount of the 1.5L Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the applicable repurchase date. A “Fundamental Change” includes certain business combination transactions involving the Company, acquisitions of more than 50% of the Company's outstanding New Common Stock by specified persons or groups, and certain delisting events with respect to the New Common Stock.
The 1.5L Convertible Notes are redeemable, in whole or in part, at the Company’s option for cash at any time, on or after March 20, 2028, and on or before the 35th scheduled trading day immediately preceding the maturity date, subject to certain conditions. Redemption is permitted only if the last reported sale price of New Common Stock exceeds (i) 175% of the conversion price for specific periods if the redemption date occurs on or before March 19, 2029 or (ii) 130% of the conversion price for specified periods if the redemption date occurs on or after March 20, 2029. The redemption price equals 100% of the principal amount of the 1.5L Convertible Notes redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.
1L Supplemental Indenture
In connection with the Company’s entrance into the 1.5L Convertible Notes Indenture and the issuance of the 1.5L Convertible Notes, the Company entered into that certain First Supplemental Indenture (the “1L Supplemental Indenture”), dated as of March 26, 2026, among the Company, Wolfspeed Texas, as subsidiary guarantor (in such capacity, the “1L Guarantor”), and
U.S. Bank Trust Company, National Association, as trustee and collateral agent (in such capacities, the “1L Indenture Agent”) to amend and waive certain provisions of that certain New Senior Secured Notes Indenture and to permit the Company and the 1L Guarantor to enter into the 1.5L Convertible Notes Indenture and the Company to issue the 1.5L Convertible Notes.
2L Supplemental Indenture
In connection with the Company’s entry into the indentures and the issuance of the notes described below, on March 26, 2026, the Company entered into separate first supplemental indentures to amend certain covenants governing its outstanding second‑lien indebtedness.
First, the Company entered into a First Supplemental Indenture (the “2L Non‑Renesas Supplemental Indenture”) by and among the Company, Wolfspeed Texas, as subsidiary guarantor (the “2L Non‑Renesas Guarantor”), and U.S. Bank Trust Company, National Association, as trustee and collateral agent (the “2L Non‑Renesas Agent”). The 2L Non‑Renesas Supplemental Indenture supplements and amends certain covenants under the 2L Non‑Renesas Convertible Notes Indenture.
In addition, on March 26, 2026, the Company entered into a First Supplemental Indenture (the “2L Renesas Supplemental Indenture”) by and among the Company, Wolfspeed Texas, as subsidiary guarantor (the “2L Renesas Guarantor”), and U.S. Bank Trust Company, National Association, as trustee and collateral agent (the “2L Renesas Agent”). The 2L Renesas Supplemental Indenture supplements and amends the 2L Renesas Convertible Notes Indenture.
Additionally, on March 26, 2026, the Company entered into a First Supplemental Indenture (the “Toggle Notes 2L Supplemental Indenture”) by and among the Company, Wolfspeed Texas, as subsidiary guarantor (the “Toggle Notes 2L Guarantor”), and U.S. Bank Trust Company, National Association, as trustee and collateral agent (the “Toggle Notes 2L Agent”). The Toggle Notes 2L Supplemental Indenture supplements and amends certain covenants under the “2L Non-Convertible Notes Indenture”).
Intercreditor Agreement
In connection with the Company’s entry into the 1.5 L Convertible Notes Indenture, on March 26, 2026, the Company, the trustees and the collateral agents party to the 1.5 L Convertible Notes Indenture and the New Senior Secured Notes Indenture entered into a First Lien/1.5 Lien Intercreditor Agreement (the “1L/1.5L Intercreditor Agreement”). The 1L/1.5L Intercreditor Agreement sets forth the respective rights with respect to the shared collateral between the noteholders under the 1.5L Convertible Notes, on the one hand, and the noteholders under the New Senior Secured Notes, on the other hand.
In addition, on March 26, 2026, the Company, the Trustee and the Collateral Agent entered into a Joinder Agreement, pursuant to which the Trustee and the Collateral Agent became parties to the existing 1L/2L Intercreditor Agreement
Events during June 2025
As of June 29, 2025, the Company was in default under the 2029 Convertible Notes and the CRD Agreement due to its previously announced decision to enter the 30 day grace period for the 2029 Convertible Note interest payment due June 2, 2025.
On June 23, 2025, the Company announced its entry into the Restructuring Support Agreement and subsequent to the end of fiscal 2025, on June 30, 2025, the Debtors filed the Chapter 11 Cases. Please refer to Note 2, "Basis of Presentation and Summary of Significant Accounting Policies" and Note 3, "Emergence from Voluntary Reorganization under Chapter 11", for more information regarding the terms of the Restructuring Support Agreement. When the Plan Effective Date occurred, except as otherwise set forth in the Plan, all notes, instruments, certificates, and other documents evidencing claims against, or interests in, the Debtors were canceled and/or updated to record such cancellation and the obligations of the Company thereunder or in any way related thereto was deemed satisfied in full and discharged.
As discussed in Note 2, "Basis of Presentation and Summary of Significant Accounting Policies" and Note 3, "Emergence from Voluntary Reorganization under Chapter 11", the filing of the Chapter 11 Cases constituted events of default under the Company's outstanding Secured Notes, Convertible Notes and the CRD Agreement. As a result, the principal and interest due under the Company's outstanding Senior Secured Notes, Convertible Notes, and CRD Agreement became immediately due and payable. However, any efforts to enforce such payment obligations were automatically stayed as a result of the filing of the Chapter 11 Cases, and the creditors’ rights of enforcement are subject to the applicable provisions of the Bankruptcy Code. Based on the facts and circumstances described above, including the defaults related to the missed interest payment on the 2029 Notes that were in grace periods as of June 29, 2025, the signing of the Restructuring Support Agreement on June 23, 2025 and subsequent event of default upon filing of the Chapter 11 Cases per the terms of the Restructuring Support Agreement on June 30, 2025, these amounts have been presented as “Current maturity on long-term borrowings” in the Company's audited Consolidated Balance Sheet at June 29, 2025.
The following sections describe the terms of the Company's outstanding debt obligations as of June 29, 2025, prior to the commencement of the Chapter 11 Cases. The capped call transactions further described below were terminated by the counterparties subsequent to the end of fiscal 2025, as the filing of the Chapter 11 Cases constituted an event of default.
2026 Convertible Notes
On April 21, 2020, the Company sold $500.0 million aggregate principal amount of the 2026 Notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act and an additional $75.0 million aggregate principal amount of the 2026 Notes pursuant to the exercise in full of the over-allotment options of the underwriters. The total net proceeds from the 2026 Notes offering was approximately $561.4 million.
The conversion rate was initially 21.1346 shares of common stock per one thousand dollars in principal amount of 2026 Notes (equivalent to an initial conversion price of approximately $47.32 per share of common stock), subject to customary anti-dilution adjustments, excluding accrued and unpaid interest. The Company could, at its election, settle conversions in cash, shares of common stock, or a combination thereof. As of the Effective Date, the 2026 Convertible Notes were discharged and terminated.
2028 Convertible Notes
On February 3, 2022, the Company sold $650.0 million aggregate principal amount of the 2028 Notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act and an additional $100.0 million aggregate principal amount of the 2028 Notes pursuant to the exercise in full of the over-allotment options of the underwriters. The total net proceeds from the 2028 Notes offering was approximately $732.3 million.
The Company used approximately $108.2 million of the net proceeds from the 2028 Notes to fund the cost of entering into capped call transactions.
The conversion rate was initially 7.8602 shares of common stock per one thousand dollars in principal amount of 2028 Notes (equivalent to an initial conversion price of approximately $127.22 per share of common stock), subject to customary anti-dilution adjustments, excluding accrued and unpaid interest. The Company could, at its election, settle conversions in cash, shares of common stock, or a combination thereof. As of the Effective Date, the 2028 Convertible Notes were discharged and terminated.
Capped Call Transactions in relation to the 2028 Notes
On January 31, 2022, in connection with the pricing of the 2028 Notes, the Company entered into privately negotiated capped call transactions with certain of the initial purchasers or affiliates thereof (the "2028 Notes Capped Call Counterparties"). In connection with the exercise by the initial purchasers of their option to purchase additional notes, the Company entered into additional privately negotiated capped call transactions (such transactions, collectively, the "2028 Notes Capped Call Transactions") with each of the 2028 Notes Capped Call Counterparties. The 2028 Notes Capped Call Transactions initially covered, subject to customary anti-dilution adjustments, the aggregate number of shares of the Company’s common stock that were initially underlying the 2028 Notes. The 2028 Capped Call Transactions were expected generally to reduce the potential dilutive effect on the common stock upon any conversion of 2028 Notes and/or offset any potential cash payments the Company was required to make in excess of the principal amount of converted 2028 Notes, as the case may be, with such reduction and/or offset subject to a cap which initially is $212.04 per share, representing a premium of 125% over the last reported sale price per share of the Company's common stock on January 31, 2022, subject to certain adjustments under the terms of the 2028 Notes Capped Call Transactions.
The 2028 Notes Capped Call Transactions were separate transactions entered into by the Company with each of the 2028 Notes Capped Call Counterparties, were not part of the terms of the 2028 Notes, and did not affect any holder’s rights under the 2028 Notes. Holders of the 2028 Notes did not have any rights with respect to the 2028 Notes Capped Call Transactions. The Capped Call transactions were discharged and terminated as of the Effective Date, as the 2028 Convertible Notes were discharged and terminated
2029 Convertible Notes
On November 21, 2022, the Company sold $1,525.0 million aggregate principal amount of the 2029 Notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act and an additional $225.0 million aggregate principal amount of the 2029 Notes pursuant to the exercise in full of the over-allotment options of the underwriters. The total net proceeds from the 2029 Notes offering was approximately $1,718.6 million.
The Company used approximately $273.9 million of the net proceeds from the 2029 Notes to fund the cost of entering into capped call transactions described below.
The conversion rate was initially 8.4118 shares of common stock per one thousand dollars in principal amount of 2029 Notes (equivalent to an initial conversion price of approximately $118.88 per share of common stock), subject to customary anti-dilution adjustments, excluding accrued and unpaid interest. The Company could, at its election, settle conversions in cash, shares of common stock, or a combination thereof. As of the Effective Date, the 2029 Convertible Notes were discharged and terminated.
Capped Call Transactions in relation to the 2029 Notes
On November 16, 2022, in connection with the pricing of the 2029 Notes, the Company entered into privately negotiated capped call transactions with certain of the initial purchasers or their affiliates and another financial institution (the "2029 Notes Capped Call Counterparties"). In connection with the exercise by the initial purchasers of their option to purchase additional notes, the Company entered into additional privately negotiated capped call transactions (such transactions, collectively, the "2029 Notes Capped Call Transactions") with each of the 2029 Notes Capped Call Counterparties. The 2029 Notes Capped Call Transactions initially covered, subject to customary anti-dilution adjustments, the aggregate number of shares of the Company’s common stock that were initially underlying the 2029 Notes. The 2029 Notes Capped Call Transactions were expected generally to reduce the potential dilutive effect on the common stock upon any conversion of 2029 Notes and/or offset any potential cash payments the Company was required to make in excess of the principal amount of converted 2029 Notes, as the case may be, with such reduction and/or offset subject to a cap which initially is $202.538 per share, representing a premium of 130% over the last reported sale price per share of our common stock on November 16, 2022, subject to certain adjustments under the terms of the 2029 Notes Capped Call Transactions.
The 2029 Notes Capped Call Transactions were separate transactions entered into by the Company with each of the 2029 Notes Capped Call Counterparties, were not part of the terms of the 2029 Notes, and did not affect any holder’s rights under the 2029 Notes. Holders of the 2029 Notes did not have any rights with respect to the 2029 Notes Capped Call Transactions. The Capped Call transactions were discharged and terminated as of the Effective Date, as the 2029 Convertible Notes were discharged and terminated.
Accounting for the Pre-Emergence Convertible Notes
The last reported sale price of the Company's common stock was not greater than or equal to 130% of the applicable conversion price for any of the Convertible Notes for at least 20 trading days in the 30 consecutive trading days ended on June 29, 2025. As a result, none of the Convertible Notes were convertible at the option of the holders through June 29, 2025.
Senior Secured Notes Amended and Restated Indenture
On June 23, 2023 (the "Issue Date"), the Company sold $1,250 million aggregate principal amount of the Senior Secured Notes. The total net proceeds from the Senior Secured Notes was approximately $1,149.3 million. The total net proceeds are net of debt issuance costs and an original issue discount of $50.0 million.
On October 11, 2024, the Company entered into the Amended and Restated Indenture (the "2030 Senior Notes Indenture"), which amended certain terms and conditions of the Senior Secured Notes and permits the Company to issue and sell $750.0 million of additional notes, subject to the fulfillment of certain conditions precedent.
On June 23, 2025, the Company entered into the Second Supplemental Indenture (the “Second Supplemental Indenture”) to the Amended and Restated Indenture, dated as of October 11, 2024, which released Wolfspeed Germany GmbH, from its obligations and any related liens under the Senior Secured Notes and excludes net proceeds of the sale of “Building 21” from the offer to repurchase requirement under the 2030 Senior Notes Indenture.
On October 22, 2024, the Company issued $250.0 million in aggregate principal amount of Senior Secured Notes pursuant to the 2030 Senior Notes Indenture and the total net proceeds were approximately $231.3 million. The total net proceeds are net of debt issuance costs and an original discount of $10.0 million.
As of June 29, 2025, the Company was in compliance with all covenants relating to the Senior Secured Notes. As of the Effective Date, the 2030 Secured Notes were discharged and terminated.
2033 CRD Agreement Amendment
In July 2023, the Company entered into the CRD Agreement with a customer, pursuant to which the customer agreed to provide the Company up to $2.0 billion in unsecured deposits. Under the CRD Agreement, the Company received an initial deposit of $1.0 billion in the first quarter of fiscal 2024 with the option to receive additional deposits up to $1.0 billion at the Company's request, subject to certain conditions during the 2024 calendar year. On February 27, 2024, the Company received an additional deposit of $500.0 million (the second draw), and on June 26, 2024, the Company received the final deposit of $500.0 million (the third draw). Unless previously terminated in accordance with its terms, the CRD Agreement would have matured on July 5, 2033, and the amount of the deposits, together with accrued and unpaid interest, would be required to be repaid to the customer at such time.
The deposits under the CRD Agreement bore interest, payable on a semi-annual basis, at a base rate of 6% per annum, with the potential for an increased variable rate of either 10% or 15% in connection with any inability of the Company to satisfy supply targets under a ten-year wafer supply agreement with the same customer. The Company could have voluntarily prepaid the deposits, in whole or in part, at any time at a price equal to 106% of the principal amount of the deposits prepaid. Upon the occurrence of a change of control, the customer could have required the Company to prepay the deposits in whole at a variable prepayment price depending on the day of prepayment.
On October 15, 2024, the Company entered into Amendment No. 1 to the CRD Agreement, which amended the existing agreement to, among other things, permit the Company to pay the accrued interest on the outstanding loans payable under the existing agreement on the last business day of each of December 2024 and June 2025 (together, the "PIK Amounts") by adding the PIK Amounts to the then outstanding principal amount of the loans rather than in cash. The interest rate on the PIK Amounts would accrue at a rate of 15.0% per annum. The amendment also permitted the Company to grant liens on additional assets in Siler City, North Carolina in connection with disbursements pursuant to governmental grants or awards under the CHIPS Act, and permitted the Company to pay a portion of interest on the Senior Secured Notes in-kind subject to the limitations set forth in the amendment to the CRD Agreement.
The CRD Agreement contained certain customary affirmative covenants, negative covenants and events of default. The CRD Agreement was discharged and terminated as of the Effective Date.
Interest Expense, net
The interest expense, net recognized is as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
Interest expense, net of capitalized interest(1) | $132.0 | | | $— | | | $263.3 | | | $214.7 | |
| Amortization of discount and issuance costs, net of capitalized interest | 16.4 | | | — | | | 48.8 | | | 28.4 | |
| Interest expense, other | 1.5 | | | 0.7 | | | 3.1 | | | 3.2 | |
| Total interest expense, net | $149.9 | | | $0.7 | | | $315.2 | | | $246.3 | |
(1): Excludes contractual interest of $99.7 million for the period from June 30, 2025 to September 29, 2025 |
The Company capitalizes interest in connection with ongoing capacity expansions.
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Interest expense capitalized | $— | | | $— | | | $72.4 | | | $28.3 | |
| Amortization of discount and debt issuance costs capitalized | — | | | — | | | 13.5 | | | 3.6 | |
| Total interest expense capitalized | $— | | | $— | | | $85.9 | | | $31.9 | |
Note 12 – Stockholders’ Equity and Pre-funded Warrants
At-The-Market Offering
On December 9, 2024, the Company established an "at-the-market" offering program (the "ATM Program") pursuant to which the Company could offer and sell, from time to time through sales agents, up to $200.0 million of the Company's common stock. The ATM Program was conducted pursuant to an equity distribution agreement (the "Equity Distribution Agreement") entered into by the Company and J.P. Morgan Securities LLC and Wells Fargo Securities, LLC (the "Managers").
The ATM Program concluded on January 14, 2025 and the Company completed the sale of approximately $200.0 million of Old Common Stock and, as such, the ATM Program automatically terminated in accordance with the terms of the Equity Distribution Agreement. In total, the Company sold and received payment for 27.8 million additional shares of Old Common Stock at a weighted average price of $7.20 per share through the ATM Program for total gross proceeds of approximately $200.0 million and net proceeds of approximately $195.2 million, after $4.0 million in commissions to the Managers and $0.8 million in other offering costs.
Securities Purchase Agreement
On March 19, 2026, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain investors in connection with a private placement offering of shares of New Common Stock and pre-funded warrants to purchase New Common Stock. On March 26, 2026, pursuant to the terms of the Securities Purchase Agreement, the Company issued and sold an aggregate of 3,250,030 shares of New Common Stock (the “Shares”) and pre-funded warrants (the “Pre-Funded Warrants” to purchase 2,000,000 shares of New Common Stock. The price per share of New Common Stock was $18.458, and the price per Pre-Funded Warrant was $18.448, resulting in aggregate gross proceeds of approximately $96.9 million, with issuance costs of $3.6 million. The Pre-Funded Warrants have an exercise price of $0.01 per underlying share of New Common Stock and are exercisable at any time until fully exercised. The Pre‑Funded Warrants do not expire until fully exercised.
The Pre-Funded Warrants are classified as equity and recorded as a component of additional paid-in capital at issuance. As of June 28, 2026, there were 2.0 million Pre-Funded Warrants outstanding.
At June 28, 2026, the Company had reserved a total of approximately 70.8 million shares of its common stock for future issuance as follows (in thousands):
| | | | | |
| Number of Shares |
| For vesting of outstanding stock units | 3,766 | |
| For future equity awards under the 2025 Long-Term Incentive Compensation Plan | 3,078 | |
| For future equity awards under the 2025 Management Incentive Plan | 5,254 | |
| |
| |
| For future issuance upon conversion of the New 2L Non-Renesas Convertible Notes | 21,836 | |
| For future issuance upon conversion of the New 2L Renesas Convertible Notes | 11,096 | |
| For future issuance upon conversion of the 1.5L Convertible Notes | 18,822 | |
| Renesas Warrants | 4,944 | |
| Pre-funded Warrants | 2,000 | |
| Total common shares reserved | 70,796 | |
Note 13 – (Loss) Income Per Share
The details of the computation of basic and diluted (loss) earnings per share are as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars, except share data) | Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Net (loss) income from continuing operations, basic | $ | (415.8) | | | $ | 420.2 | | | $ | (1,609.2) | | | $ | (573.6) | |
| | | | | | | |
| Net loss from discontinued operations, basic | — | | | — | | | — | | | (290.6) | |
| | | | | | | |
| Weighted average number of common shares - basic (in thousands) | 39,094 | | | 156,185 | | | 141,320 | | | 125,693 | |
| | | | | | | |
| (Loss) earnings per share - basic: | | | | | | | |
| Continuing operations | ($10.64) | | | $2.69 | | | ($11.39) | | | ($4.56) | |
| Discontinued operations | $— | | | $— | | | $— | | | ($2.31) | |
| | | | | | | |
| Net (loss) income from continuing operations, diluted | ($415.8) | | | $420.2 | | | ($1,609.2) | | | ($573.6) | |
| | | | | | | |
| Net loss from discontinued operations, diluted | $— | | | $— | | | $— | | | ($290.6) | |
| | | | | | | |
| Weighted-average number of shares outstanding used to compute net (loss) earnings per share attributable to common stockholders, basic (in thousands) | 39,094 | | 156,185 | | | 141,320 | | | $125,693 | |
| Weighted-average effect of potentially dilutive securities: | | | | | | | |
1.75% Convertible Notes | — | | | 12,152 | | | — | | | — | |
0.25% Convertible notes | — | | | 5,895 | | | — | | | |
1.875% Convertible Notes | — | | | 14,721 | | | — | | | |
| RSUs (Predecessor) | — | | | 99 | | | — | | | |
| Weighted-average number of shares outstanding used to compute net (loss) earnings per share attributable to common stockholders, diluted (in thousands) | 39,094 | | 189,052 | | | 141,320 | | | 125,693 | |
| | | | | | | |
| Net (loss) income from continuing operations per share attributable to common stockholders, diluted | ($10.64) | | | $2.22 | | | ($11.39) | | | ($4.56) | |
| Net loss per share attributable to common stockholders for discontinued operations | $— | | | $— | | | $— | | | ($2.31) | |
Diluted net (loss) earnings per share is the same as basic net (loss) earnings per share for the periods presented due to potentially dilutive items being anti-dilutive given the Company's net loss from continuing operations.
For the period from June 30, 2025 to September 29, 2025 and September 30, 2025 to June 28, 2026 and fiscal years ended June 29, 2025 and June 30, 2024, 0.0 million, 51.8 million, 0.0 million and 0.0 million, respectively of diluted shares related to convertible notes, calculated under the if-converted method, were excluded from the calculation of diluted (loss) earnings per share because their effect would be anti-dilutive. For the period from June 30, 2025 to September 29, 2025 and September 30, 2025 to June 28, 2026 and fiscal years ended June 29, 2025 and June 30, 2024, 0.0 million, 4.9 million, 0.0 million and 0.0 million, respectively, of diluted shares related to warrants were excluded from the calculation of diluted (loss) earnings per share because their effect would be anti-dilutive. For the period from June 30, 2025 to September 29, 2025 and September 30, 2025 to June 28, 2026 and fiscal years ended June 29, 2025 and June 30, 2024, 0.0 million, 3.8 million, 5.6 million and 4.4 million, respectively, of diluted shares related to share-based payments were excluded from the calculation of diluted (loss) earnings per share because their effect would be anti-dilutive.
Future earnings per share of the Company are also subject to dilution from conversion of its convertible notes under certain conditions as described in Note 11, “Debt.”
Note 14 – Stock-Based Compensation
Overview of Employee Stock-Based Compensation Plans
The Company currently has two equity-based compensation plans, the 2025 Long-Term Incentive Plan (the “2025 LTIP”) and the 2025 Management Incentive Plan (the “2025 MIP”), which each provide for the grant of options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance stock units, performance units, other awards, or a combination thereof. At June 28, 2026, there were 4.1 million shares authorized for issuance under the 2025 LTIP and 3.1 million shares remaining for future grants. At June 28, 2026, there were 8.1 million shares authorized for issuance under the 2025 MIP and 5.3 million shares remaining for future grants.
Prior to the Effective Date, the Company had two equity-based compensation plans, the 2023 Long-Term Incentive Compensation Plan (the "2023 LTIP") and the 2025 Inducement Award Plan (the "Inducement Plan"), from which stock-based compensation awards can be granted to employees and, in the case of the 2023 LTIP, directors. The terms of the Inducement Plan are substantially similar to the 2023 LTIP but with such other terms and conditions intended to comply with Section 303A.08 of the New York Stock Exchange Company Listed Manual. The 2023 LTIP and the Inducement Plan provided for awards in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units and other awards.
The Company also previously had an Employee Stock Purchase Plan ("ESPP") that provided employees with the opportunity to purchase common stock at a discount. In April 2025, the Compensation Committee approved the termination of the ESPP, which was effective immediately. The ESPP limited employee contributions to 15% of each employee’s compensation (as defined in the plan) and allowed employees to purchase shares at a 15% discount, subject to IRS limitations. The ESPP provided for a twelve-month participation period, divided into two equal six-month purchase periods, and also provided a look-back feature. At the end of each six-month period in April and October, participants could purchase the Company’s common stock through the ESPP at a 15% discount to the fair market value of the common stock on the first day of the twelve-month participation period or the purchase date, whichever is lower. The ESPP also provided an automatic reset feature to start participants on a new twelve-month participation period if the fair market value of common stock declines during the first six-month purchase period.
Restricted Stock Units
A summary of nonvested restricted stock units (RSUs) outstanding as of June 28, 2026 and changes during the year then ended is as follows (shares in thousands):
| | | | | | | | | | | |
| Number of RSUs | | Weighted Average Grant-Date Fair Value |
| Nonvested at June 29, 2025 (Predecessor) | 4,627 | | | $32.41 | |
| Granted | — | | | — | |
| Vested | (1,216) | | | 38.17 | |
| Forfeited | (219) | | | 54.91 | |
| Nonvested at September 28, 2025 (Predecessor) | 3,192 | | | 27.25 | |
| Forfeited | (3,192) | | | 27.25 | |
| Nonvested at September 29, 2025 (Predecessor) | — | | | $— | |
| | | |
| Nonvested at September 30, 2025 (Successor) | — | | | $— | |
| Granted | 4,108 | | | 24.51 | |
| Vested | (110) | | | 22.91 | |
| Forfeited | (232) | | | 23.33 | |
| Nonvested at June 28, 2026 (Successor) | 3,766 | | | $24.63 | |
The aggregate fair value of awards vested in the period from June 30, 2025 to September 29, 2025 and from September 30, 2025 to June 28, 2026 and the fiscal years ended June 29, 2025 and June 30, 2024, based on the market price of the Company's common stock on the vesting date, was $1.9 million $4.2 million, $13.1 million and $55.2 million, respectively.
As of June 28, 2026, there was $73.5 million of unrecognized compensation cost related to nonvested awards, which is expected to be recognized over a weighted average period of 2.18 years.
Stock-Based Compensation Valuation and Expense
Total stock-based compensation expense was classified in the consolidated statements of operations as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Cost of revenue, net | $10.7 | | | $7.8 | | | $36.9 | | | $28.5 | |
| Research and development | 2.7 | | | 2.2 | | | 11.6 | | | 11.4 | |
| Sales, general and administrative | 13.7 | | | 3.6 | | | 24.8 | | | 45.0 | |
| Total stock-based compensation expense | $27.1 | | | $13.6 | | | $73.3 | | | $84.9 | |
Stock-based compensation expense may differ from the impact of stock-based compensation to additional paid in capital due to manufacturing related stock-based compensation capitalized within inventory.
The Black-Scholes and Monte Carlo option pricing models require the input of highly subjective assumptions. The assumptions listed below represent management's best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if other assumptions had been used, recorded share-based compensation expense could have been materially different from that depicted above.
The range of assumptions used to value stock issued under the ESPP were as follows:
| | | | | | | | | | | | | | | |
| | | | | Predecessor |
| | | | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Risk-free interest rate | | | | | 4.28 - 5.21% | | 5.44 - 5.54% |
| Expected life, in years | | | | | 0.5 - 1.0 | | 0.5 - 1.0 |
| Volatility | | | | | 73.7 - 100.2% | | 73.5 - 74.4% |
| Dividend yield | | | | | — | | | — | |
The range of assumptions used for performance-based awards with market conditions were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Risk-free interest rate | 3.55 | % | | 0.00% | | 3.92% | | 4.52% |
| Expected life, in years | 2.56 | | 0.0 | | 3.0 | | 3.0 |
| Expected volatility | 52.4 | % | | 0.0% | | 67.4% | | 65.9% |
| Average correlation coefficient of peer companies | 0.39 | | 0 | | 0.41 | | 0.44 |
| Dividend yield | — | | | — | | | — | | | — | |
Awards are valued using the Monte Carlo model. All performance-based awards with market conditions for each fiscal year presented were issued on a single date each year and therefore no range is shown.
The following describes each of these assumptions and the Company’s methodology for determining each assumption:
Risk-Free Interest Rate
The Company estimates the risk-free interest rate using the United States Treasury bill rate with a remaining term equal to the expected life of the award.
Expected Life
The expected life represents the period the awards are expected to be outstanding. In determining the appropriate expected life of its stock options, the Company segregates its grantees into categories based upon employee levels that are expected to be indicative of similar option-related behavior. The expected useful lives for each of these categories are then estimated giving consideration to (1) the weighted average vesting periods, (2) the contractual lives of the stock options, (3) the relationship between the exercise price and the fair market value of the Company’s common stock, (4) expected employee turnover, (5) the expected future volatility of the Company’s common stock, and (6) past and expected exercise behavior, among other factors.
Expected Volatility
The Company estimates expected volatility for the ESPP awards, giving consideration to the expected life of the respective award, the Company’s current expected growth rate, implied volatility in traded options for its common stock, and the historical volatility of its common stock. For purposes of estimating volatility for use in the Monte Carlo model for the market-based awards, the Company utilizes historical volatilities of the Company and the members of the defined peer group.
Expected Dividend Yield
The Company estimates the expected dividend yield by giving consideration to its current dividend policies as well as those anticipated in the future considering the Company’s current plans and projections. The Company has not historically issued dividends.
Correlation Coefficient
The correlation coefficients are calculated based upon the price data used to calculate the historical volatilities and are used to model the way in which each entity tends to move in relation to its peers.
Note 15 – Income Taxes
Effective June 30, 2025, the Company adopted the new income tax disclosure standard (ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures) on a prospective basis. Accordingly, the tables presenting the Company's income tax provision and effective tax rate reconciliation reflect the new standard for the periods from June 30, 2025 to September 29, 2025 and the period from September 30, 2025 to June 28, 2026, while fiscal year 2025 and Fiscal year 2024 disclosures will continue to follow the previous disclosure requirements.
The following table presents the reconciliation of the statutory U.S. federal income tax rate to the effective tax rate, pursuant to the disclosure requirements of ASU 2023-09:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 |
| (in millions of U.S. Dollars, except for percentages) | Amount | | Percent | | Amount | | Percent |
| U.S. Federal Statutory Tax Rate | ($87.0) | | | 21.0 | % | | $89.0 | | | 21.0 | % |
| | | | | | | |
| Nontaxable or Nondeductible items: | | | | | | | |
| Transaction fees | — | | | — | % | | 14.6 | | | 3.5 | % |
| Stock compensation | — | | | — | % | | 21.9 | | | 5.2 | % |
| Effects of restructuring | — | | | — | % | | 60.0 | | | 14.1 | % |
| Changes in valuation allowances | 88.4 | | | (21.3) | % | | (186.2) | | | (44.0) | % |
| Other | (1.2) | | | 0.3 | % | | 3.8 | | | 0.9 | % |
State and Local Income Taxes, Net of Federal Income Tax Effect(1) | 0.1 | | | — | % | | — | | | — | % |
| Foreign Tax Effects | 1.1 | | | (0.3) | % | | 0.4 | | | 0.1 | % |
| Income tax expense and effective tax rate | $1.4 | | | (0.3) | % | | $3.5 | | | 0.8 | % |
| (1): The states that contributed greater than 50% of the tax effect in this category include California and Massachusetts. |
The following table presents the reconciliation of the statutory U.S. federal income tax rate to the effective tax rate for the years ended June 29, 2025 and June 30, 2024, prior to the adoption of ASU 2023-09:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | Predecessor |
| | | | | | | | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| (in millions of U.S. Dollars) | | | | | | | | | Amount | | Percent | | Amount | | Percent |
| Federal income tax provision at statutory rate | | | | | | | | | ($340.0) | | | 21 | % | | ($120.2) | | | 21 | % |
| (Decrease) increase in income tax expense resulting from: | | | | | | | | | | | | | | | |
| State tax provision, net of federal benefit | | | | | | | | | (13.8) | | | 1 | % | | (5.0) | | | 1 | % |
| | | | | | | | | | | | | | | |
| Tax exempt interest | | | | | | | | | (0.1) | | | — | % | | (0.4) | | | — | % |
| | | | | | | | | | | | | | | |
| (Decrease) increase in tax reserve | | | | | | | | | (0.4) | | | — | % | | (2.0) | | | — | % |
| | | | | | | | | | | | | | | |
| Research and development credits | | | | | | | | | (7.3) | | | 1 | % | | (9.7) | | | 2 | % |
| | | | | | | | | | | | | | | |
| Increase (decrease) in valuation allowance | | | | | | | | | 309.1 | | | (19) | % | | 127.0 | | | (22) | % |
| | | | | | | | | | | | | | | |
| Stock-based compensation | | | | | | | | | 14.2 | | | (1) | % | | 8.8 | | | (2) | % |
| Statutory rate differences | | | | | | | | | 0.1 | | | — | % | | — | | | — | % |
| Foreign earnings taxed in U.S. | | | | | | | | | 3.5 | | | — | % | | 0.4 | | | — | % |
| Goodwill Impairment | | | | | | | | | 23.1 | | | (1) | % | | — | | | — | % |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Provision to return adjustments | | | | | | | | | 0.9 | | | — | % | | (0.4) | | | — | % |
| | | | | | | | | | | | | | | |
| Impact of rate changes | | | | | | | | | (3.4) | | | — | % | | 0.4 | | | — | % |
| Expiration of attributes | | | | | | | | | 0.1 | | | — | % | | 2.0 | | | — | % |
| Pre-petition charges | | | | | | | | | 4.1 | | | — | % | | — | | | — | % |
| Other | | | | | | | | | 0.2 | | | — | % | | 0.2 | | | — | % |
| Income tax (benefit) expense and effective tax rate | | | | | | | | | ($9.7) | | | 1 | % | | $1.1 | | | — | % |
Income taxes paid in federal, state and foreign jurisdictions are immaterial.
The following were the components of (loss) income before income taxes:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Domestic | ($419.7) | | | $431.4 | | | ($1,619.2) | | | ($572.2) | |
| Foreign | 5.3 | | | (7.7) | | | 0.3 | | | (0.3) | |
| (Loss) income before income taxes | ($414.4) | | | $423.7 | | | ($1,618.9) | | | ($572.5) | |
| | | | | | | |
The following were the components of income tax (benefit) expense:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Current: | | | | | | | |
| Federal | $— | | | $0.1 | | | $— | | | $— | |
| Foreign | 0.8 | | | 0.1 | | | 0.6 | | | 0.9 | |
| State | — | | | — | | | — | | | 0.2 | |
| Total current | 0.8 | | | 0.2 | | | 0.6 | | | 1.1 | |
| Deferred: | | | | | | | |
| Federal | 0.9 | | | 3.2 | | | (10.5) | | | — | |
| Foreign | (0.4) | | | — | | | 0.5 | | | — | |
| State | 0.1 | | | 0.1 | | | (0.3) | | | — | |
Total deferred(1) | 0.6 | | | 3.3 | | | (10.3) | | | — | |
| Income tax expense (benefit) | $1.4 | | | $3.5 | | | ($9.7) | | | $1.1 | |
(1): For the period ended September 29, 2025, expenses included $2.3 million impact from fresh start accounting and implementation of the Plan. See Note 4, "Fresh Start Accounting," for further information. |
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities were as follows:
| | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | June 28, 2026 | | June 29, 2025 |
| Deferred tax assets: | | | |
| Compensation | $5.9 | | | $8.3 | |
| Inventories | 41.0 | | | 45.3 | |
| Sales return reserve and allowance for bad debts | 11.3 | | | 8.1 | |
| | | |
| Federal and state net operating loss carryforwards | 133.0 | | | 691.0 | |
| Federal income tax credits | 79.2 | | | 77.0 | |
| State income tax credits | 0.7 | | | 0.7 | |
| 48C investment tax credits | 35.7 | | | 35.7 | |
| Property and Equipment | 534.4 | | | — | |
| Investments | 0.3 | | | 0.6 | |
| Stock-based compensation | 5.9 | | | 9.0 | |
| Deferred revenue | 16.5 | | | 25.0 | |
| Lease liabilities | 24.0 | | | 35.1 | |
| Capitalized research and development | 63.5 | | | 120.1 | |
| Convertible notes | — | | | 58.5 | |
| Nondeductible interest carryforward | 115.9 | | | 95.3 | |
| Other | 7.4 | | | 14.1 | |
| Total gross deferred assets | 1,074.7 | | | 1,223.8 | |
| Less valuation allowance | (930.6) | | | (1,041.4) | |
| Deferred tax assets, net | 144.1 | | | 182.4 | |
| | | |
| Deferred tax liabilities: | | | |
| Property and equipment | — | | | (122.4) | |
| Intangible assets | (85.2) | | | (5.0) | |
| Other long-term investments | — | | | (9.0) | |
| Prepaid taxes | (0.5) | | | (0.5) | |
| Foreign earnings recapture | (4.2) | | | (4.2) | |
| Taxes on unremitted foreign earnings | (1.0) | | | (7.0) | |
| Lease assets | (21.8) | | | (29.1) | |
| Convertible notes and debt | (32.2) | | | — | |
| Other | — | | | (4.6) | |
| | | |
| Total gross deferred liability | (144.9) | | | (181.8) | |
| Deferred tax liability, net | ($0.8) | | | $0.6 | |
The components giving rise to the net deferred tax assets (liabilities) have been included in the consolidated balance sheets as follows:
| | | | | | | | | | | |
| Successor |
| Balance at June 28, 2026 |
| (in millions of U.S. Dollars) | Assets | | Liabilities |
| U.S. federal income taxes | $— | | | ($1.9) | |
| Foreign income taxes | 1.1 | | | — | |
| Total | $1.1 | | | ($1.9) | |
| | | | | | | | | | | |
| Predecessor |
| Balance at June 29, 2025 |
| (in millions of U.S. Dollars) | Assets | | Liabilities |
| U.S. federal income taxes | $— | | | ($0.5) | |
| Foreign income taxes | 1.1 | | | — | |
| Total | $1.1 | | | ($0.5) | |
The Company weighs all available evidence, both positive and negative, to estimate if sufficient future taxable income will be generated to utilize the existing deferred tax assets by jurisdiction. Primarily as the result of significant cumulative losses, the Company has concluded that it is necessary to recognize a full valuation allowance against its United States deferred tax assets as of June 28, 2026. As of June 28, 2026 and June 29, 2025, the United States valuation allowance was $930.4 million and $1,041.3 million, respectively. For the fiscal year ended June 28, 2026, the Company decreased the United States valuation allowance by $110.9 million largely due to decreases in net operating loss carryforwards as the result of tax cancellation of debt ("COD") Income offset by increases in deferred tax assets related to property and equipment and interest carryforwards. The Company has a full valuation allowance against its state deferred tax assets and an immaterial valuation allowances against deferred tax assets in international jurisdictions.
As of June 28, 2026, the Company had approximately $615.7 million of federal net operating loss carryovers which are fully offset by liabilities for unrecognized tax benefits and valuation allowance. The Company's federal net operating loss carryovers have no carry forward expiration limitation. The Company has $198.1 million of state net operating loss carryovers which are fully offset due to a valuation allowance. The Company's state net operating loss carryovers begin to expire in fiscal 2027. Additionally, the Company had $118.9 million of federal credit carryforwards, which are fully offset by liabilities for unrecognized tax benefits and a valuation allowance, and $0.7 million of state income tax credit carryforwards, which are fully offset by a valuation allowance. The federal and state income tax credit carryforwards will begin to expire in fiscal 2031 and fiscal 2027, respectively. As of June 28, 2026, the Company had approximately $2.2 million of foreign net operating loss carryovers, of which $0.4 million are offset by a valuation allowance. The Company's foreign net operating loss carryovers have no carry forward limitation.
As discussed in Note 3 – Emergence from Voluntary Reorganization under Chapter 11, the implementation of the Plan resulted in the discharge of indebtedness which gave rise to approximately $3.4 billion of COD income for U.S. federal income tax purposes which was excluded from taxable income. The exclusion from taxable income under Section 108 of the Internal Revenue Code of 1986, as amended (the "Code") resulted in the Company reducing its gross net operating loss by $3.4 billion. For U.S. federal income tax purposes, the Plan did not result in the close of its tax year. For U.S. federal income tax purposes, the reduction was first applied to the fiscal 2026 tax year loss, which includes both predecessor and successor periods, and then to the earliest available net operating loss. While for U.S. GAAP purposes the implementation of the Plan resulted in fair market value adjustments to the Company's basis in assets, for U.S. federal income tax purposes, the adjustments were limited to the reductions to tax attributes pursuant Section 108 discussed above. As a result, the Fresh Start Adjustments discussed in Note 3 - Emergence from Voluntary Reorganization under Chapter 11 generally resulted in an increase to the Company’s deferred tax assets, offset by a change in valuation allowance.
During the fiscal year ended June 28, 2026, as part of the restructuring under the Plan, the Company experienced an “ownership change” within the meaning of Section 382 of the Internal Revenue Code of 1986, as amended (“Section 382”). As a result, the Company’s ability to utilize its U.S. federal NOL and certain other tax attributes arising before the ownership change is subject to annual limitations.
The Company has analyzed the effect of this ownership change and expects that certain tax credit carryforwards and state net operation losses may expire unused. Future changes in the Company’s stock ownership, including those that may be outside the
Company’s control, could result in additional ownership changes under Section 382, which may further limit the Company’s ability to utilize its NOLs and other tax attributes.
In July 2025, the "One Big Beautiful Bill Act" (the "OBBBA") was enacted, making multiple changes to federal income tax laws that affect US federal income taxes of non-US operations and the timing of deductions related to 100% bonus deprecation, expense of domestic research and development costs, and interest. As the result of implementation of OBBBA, the Company’s deferred tax assets for domestic research and development costs was partially accelerated resulting in a deduction of $266.7 million in the current fiscal year.
U.S. GAAP requires a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is cumulatively more than 50% likely to be realized upon ultimate settlement.
As of June 29, 2025, the Company’s liability for unrecognized tax benefits was $8.3 million. During the fiscal year ended June 28, 2026, the liability for unrecognized tax benefits increased by $0.1 million, which was related to prior year tax positions. In addition, there was a decrease of $0.3 million for expiration of statute of limitations. As a result, the total liability for unrecognized tax benefits as of June 28, 2026 was $8.1 million. If any portion of this $8.1 million is recognized, the Company will then include that portion in the computation of its effective tax rate. Although the ultimate timing of the resolution and/or closure of audits is highly uncertain, the Company believes it is reasonably possible that $0.5 million of gross unrecognized tax benefits will change in the next 12 months as a result of statute requirements or settlement with tax authorities.
The following is a tabular reconciliation of the Company’s change in uncertain tax positions:
| | | | | | | | | | | | | | | | | | | | | | | |
| Successor | | Predecessor |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | Period from June 30, 2025 to September 29, 2025 | | Fiscal Year Ended June 29, 2025 | | Fiscal Year Ended June 30, 2024 |
| Balance at beginning of period | $8.3 | | | $8.3 | | | $9.4 | | | $9.8 | |
| Increases related to prior year tax positions | 0.1 | | | — | | | — | | | — | |
| Decreases related to prior year tax positions | — | | | — | | | (1.1) | | | (0.1) | |
| | | | | | | |
| Expiration of statute of limitations for assessment of taxes | (0.3) | | | — | | | (0.4) | | | (2.0) | |
| Increases related to current year positions | — | | | — | | | 0.4 | | | 1.7 | |
| Balance at end of period | $8.1 | | | $8.3 | | | $8.3 | | | $9.4 | |
The Company's policy is to include interest and penalties related to unrecognized tax benefits within the income tax expense (benefit) line item in the consolidated statements of operations. Interest and penalties relating to unrecognized tax benefits recognized in the consolidated statements of operations was less than $0.1 million for the period from June 30, 2025 to September 29, 2025 and September 30, 2025 to June 28, 2026 and the fiscal years ended June 29, 2025, and June 30, 2024.
For Federal purposes, the Company is generally no longer subject to tax assessments for fiscal years prior to 2023. For state tax returns, the Company is generally no longer subject to tax examinations for fiscal years prior to 2022. For foreign purposes, the Company is generally no longer subject to examination for tax periods prior to 2016. Certain carryforward tax attributes generated in prior years remain subject to examination, adjustment and recapture.
The Company provides for income taxes on the earnings of foreign subsidiaries unless such earnings are considered indefinitely reinvested outside the United States. As of June 28, 2026, the Company has approximately $32.1 million of undistributed earnings from certain non-U.S. subsidiaries, of which $6.8 million was not considered indefinitely reinvested. The Company would incur approximately $1.0 million of foreign income taxes upon repatriation of these earnings. The Company has not provided income taxes on the remaining $25.3 million of undistributed foreign earnings because it intends to reinvest these earnings indefinitely in foreign operations. If these earnings were subsequently repatriated to the United States, the Company would be required to pay approximately $2.6 million in taxes.
Note 16 – Commitments and Contingencies
The Company is currently a party to various legal proceedings, including the case described below. While management presently believes that the ultimate outcome of such proceedings, individually and in the aggregate, will not materially harm the Company’s financial position, cash flows, or overall trends in results of operations, legal proceedings are subject to inherent uncertainties, and unfavorable rulings could occur. An unfavorable ruling could include monetary damages or, in matters for which injunctive relief or other conduct remedies may be sought, an injunction prohibiting the Company from selling one or more products at all or in particular ways. Were unfavorable final outcomes to occur, there exists the possibility of a material adverse impact on the Company’s business, results of operations, financial position and overall trends. The outcomes in these matters are not reasonably estimable.
In October 2021, The Trustees of Purdue University ("Purdue") filed a complaint against the Company in the U.S. District Court for the Middle District of North Carolina, alleging infringement of U.S. Patent Nos. 7,498,633 (the "'633 Patent"), entitled "High-voltage power semiconductor device," and 8,035,112 (the "'112 Patent"), entitled "SIC power DMOSFET with self-aligned source contact." In the complaint, Purdue also alleged willful infringement and sought unspecified monetary damages and attorneys’ fees. In August 2022, Purdue voluntarily withdrew all allegations as to the '112 Patent after having disclaimed all rights to that patent. On February 25, 2025, the Company entered into a confidential settlement agreement with Purdue resolving all remaining claims against the Company. A stipulation for dismissal was filed with the court, and the court dismissed the case with prejudice on March 17, 2025. The Company recorded the entire financial impact of the settlement during the third quarter of fiscal 2025 as the loss became probable and estimable when the settlement was made.
On November 15, 2024, the Company and certain of its former executive officers were named as defendants (“Defendants”) in a securities class action lawsuit captioned Gary Zagami v Wolfspeed, Inc., et al., Case No. 6:24-cv-01395, which was filed in the United States District Court for the Northern District of New York. The complaint alleges that Defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Rule 10b-5 promulgated thereunder by making false and/or misleading statements between August 16, 2023 and November 6, 2024 in connection with the operational status, profitability, and growth potential of the Mohawk Valley fabrication facility, among other things. The complaint seeks unspecified compensatory damages and other relief. On January 8, 2025 and January 13, 2025, respectively, stockholders filed two additional lawsuits regarding the same matters and against the same Defendants—Maizner v. Wolfspeed, Inc., et al. (No. 6:25-cv-00046) and Ferreira v. Wolfspeed, Inc., et al. (No. 6:25-CV-00062)—in the U.S. District Court for the Northern District of New York, which consolidated the Zagami, Maizner, and Ferreira actions and appointed co-lead plaintiffs and co-lead counsel on February 24, 2025. Co-lead plaintiffs filed an amended complaint on May 5, 2025, and Defendants moved to transfer the consolidated action to the U.S. District Court for the Middle District of North Carolina on June 4, 2025. On December 22, 2025, the United States District Court for the Northern District of New York granted the motion to transfer, and the case was electronically transferred to the Middle District of North Carolina on January 7, 2026. On February 20, 2026, Defendants filed a motion to dismiss the amended complaint, and briefing concluded on June 5, 2026. On July 20, 2026, the District Judge held oral argument on the motion to dismiss. On August 12, 2026, the District Judge granted Defendants' motion to dismiss without prejudice and entered judgment dismissing the amended complaint in its entirety. The plaintiffs may appeal or seek to further amend the amended complaint.
The Company intends to vigorously defend against the claims in the above-referenced class action.
We are also pursuing claims for damages arising from alleged patent infringement, including the case described below.
The Company filed a complaint for patent infringement against Navitas Semiconductor Corp., Navitas Semiconductor Ireland, LLC, GeneSic Semiconductor LLC, and Navitas Semiconductor USA, Inc. (collectively, "Navitas") on July 7, 2026 in the United States District Court of Delaware. The complaint seeks injunctive relief and damages for infringement of five U.S. patents owned by the Company (U.S. Patent No. 8,169,005, U.S. Patent No. 10,998,418, U.S. Patent No. 10,886,396, U.S. Patent No. 10,749,443 and U.S. Patent No. 11,888,392) by Navitas' GaN-based FET products and SiC-based products. Navitas' response to the complaint is due August 28, 2026. While management believes the claims have merit, the outcome of these matters is inherently uncertain. Therefore, no amounts related to potential recoveries have been reflected in the consolidated financial statements.
Grant Disbursement Agreement ("GDA") with the State of New York
The Company currently has a GDA with the State of New York Urban Development Corporation (doing business as Empire State Development). The GDA provides a potential total grant amount of $500.0 million to partially and fully reimburse the Company for certain property, plant and equipment costs related to the Company's construction of its silicon carbide device fabrication facility in Marcy, New York.
The GDA was signed in the fourth quarter of fiscal 2020 and requires the Company to satisfy a number of objectives for the Company to receive reimbursements through the span of the 13-year agreement. These objectives include maintaining a certain level of local employment, investing a certain amount in locally administered research and development activities and the payment of an annual commitment fee for the first six years. Additionally, the Company has agreed, under a separate agreement (the SUNY Agreement), to sponsor the creation of two endowed faculty chairs and fund a scholarship program at SUNY Polytechnic Institute.
As of June 28, 2026, the annual cost of satisfying the objectives of the GDA and the SUNY Agreement, excluding the direct and indirect costs associated with employment, varies from $2.2 million to $5.2 million per year through fiscal 2031.
As of June 28, 2026, the Company has received a total of $500.0 million as a result of GDA reimbursements, all of which has been received in cash.
Supply Commitments
From time to time, the Company may enter into agreements with its suppliers which require the Company to commit to a minimum of product purchases or make capacity reservation deposits.
In fiscal 2023, the Company entered into an agreement with a supplier which requires a minimum commitment of product purchases on a take-or-pay basis of $200.0 million over the life of the contract. During the third quarter of fiscal 2025, the Company amended the agreement to extend the term of the contract through December 2029 and modify the remaining minimum annual purchase commitments. During the periods from June 30, 2025 to September 29, 2025 and September 30, 2025 to June 28, 2026 and the fiscal year ended June 29, 2025 and June 30, 2024 the Company purchased $4.4 million, $14.7 million, $20.0 million, and $36.7 million of product under this agreement. As of June 28, 2026, minimum future product purchases for the remainder of 2026, 2027, 2028 and 2029 are $22.2 million, $38.0 million, $40.0 million and $42.0 million, respectively.
In addition, the Company paid quarterly capacity reservation deposits through the second quarter of fiscal 2026. The capacity reservation deposits totaled $60.0 million and are refundable through credits on future product purchases. The Company paid $3.5 million in the period from June 30, 2025 to September 29, 2025, $0.0 million in the period from September 30, 2025 to June 28, 2026, $18.1 million in fiscal 2025 and $32.9 million in fiscal 2024 in connection with the agreement. As of June 28, 2026, the Company has paid the full $60 million in connection with the agreement, which is recognized and $37.9 million remains in prepaid expenses and other long-term assets on the consolidated balance sheet.
In the second quarter of fiscal 2024, the Company entered into an agreement with another supplier which requires a minimum commitment of product purchases on a take-or-pay basis of $86.4 million over the life of the contract. During the periods from June 30, 2025 to September 29, 2025 and September 30, 2025 to June 28, 2026 and the fiscal years ended June 29, 2025 and June 30, 2024, the Company purchased $7.2 million, $12.0 million, $26.4 million and $19.2 million, respectively, of product under this agreement which satisfied the minimum future product purchases for the period. Minimum future product purchases for the remainder of fiscal 2027 are $21.6 million, respectively.
The Company will also be required to purchase electricity for its facilities in Siler City, North Carolina and Durham, North Carolina under a long-term electricity supply agreement with minimum volume and spend requirements of approximately $55.3 million over the next 4 years and approximately $22.7 million over the next 7 years, respectively.
The Company has entered into an agreement with a supplier for equipment that has not yet been delivered or accepted by the Company. While the Company has not accepted delivery of the equipment and, therefore, the arrangement has not commenced as a lease under ASC 842, the Company is contractually obligated to make monthly payments of $0.2 million for the next 181 months.
The Company reviews the terms of all its long-term supply agreements and assesses the need for any accruals for estimated losses on adverse purchase commitments, such as lower of cost or net realizable value adjustments that will not be recovered by future sales prices and the recoverability of assets related to capacity deposits, as necessary.
Note 17 – Concentrations of Risk
Financial instruments, which may subject the Company to a concentration of risk, consist principally of short-term investments, cash equivalents, accounts receivable and long-term receivables. Short-term investments consist primarily of municipal bonds, corporate bonds, U.S. agency securities, U.S. treasury securities, commercial paper and certificates of deposit. The Company’s cash equivalents consist primarily of money market funds. Certain bank deposits may at times be in excess of the FDIC insurance limits.
The Company sells its products on account to manufacturers, distributors and others worldwide and generally requires no collateral.
For the period from June 30, 2025 to September 29, 2025, two customers represented 13% and 28% of revenue, respectively. For the period from September 30, 2025 to June 28, 2026, two customers represented 11% and 27% of revenue, respectively. For the fiscal year ended June 29, 2025, two customers represented 19% and 18% of revenue, respectively. For the fiscal year ended June 30, 2024, two customers represented 13% and 24% of revenue, respectively. No other customers individually accounted for more than 10% of revenue for the periods from June 30, 2025 to September 29, 2025 and from September 30, 2025 to June 28, 2026 and the fiscal years ended June 29, 2025 and June 30, 2024.
Two customers accounted for 15% and 11% of the accounts receivable balance as of June 28, 2026, respectively. Two customers accounted for 26% and 12% of the accounts receivable balance as of June 29, 2025, respectively. No other customers accounted for more than 10% of the accounts receivable balance as of June 28, 2026 and June 29, 2025.
Note 18 - Restructuring
2025 Restructuring Plan
During the first quarter of fiscal 2025, the Company initiated a headcount reduction and facility closure and consolidation plan intended to optimize its cost structure as the Company accelerates its transition from 150mm to 200mm silicon carbide devices (collectively with the subsequent updates described below, the 2025 Restructuring Plan).
The actions taken under the 2025 Restructuring Plan resulted in the closure of the Company's 150mm device fabrication facility in Durham, North Carolina as well as a realignment of related activities across the geographic regions in which the Company operates. The Company also consolidated its manufacturing footprint for epitaxy products by closing operations at its facility in Farmers Branch, Texas and impairing assets associated with the Saarland, Germany site during fiscal 2025. In addition, the Company took steps to optimize the allocation of resources across various functional groups. The Company also implemented a voluntary separation program for a limited number of eligible employees based on their age and years of service. During the third and fourth quarters of fiscal 2025, the Company increased the scope of the planned headcount reductions, primarily in its Materials Products operations and supporting roles.
The 2025 Restructuring Plan resulted in a cumulative total headcount reduction of approximately 28%. The Company's 150mm device fabrication facility in North Carolina ceased production in the second quarter of fiscal 2026.
The costs incurred as a result of the 2025 Restructuring Plan primarily include severance and employee benefit costs, voluntary termination benefits, and other exit costs that qualify as exit and disposal costs under ASC 420, "Exit or Disposal Cost Obligations". The involuntary severance costs incurred were provided under an ongoing benefit arrangement and were therefore recorded once they were both probable and reasonably estimable in accordance with the provisions of ASC 712-10, “Nonretirement Postemployment Benefits”. Additionally, the Company incurred additional facility closure-related costs related to these activities, including asset-related charges, fixed manufacturing costs that will be eliminated as a result of this plan, and other incremental costs related to the exit of certain facilities.
Including these additional facility closure-related costs, the Company incurred approximately $457 million of total restructuring and related costs, including approximately $73 million of involuntary and voluntary severance costs, approximately $124 million of other closure-related cash costs, and approximately $260 million of charges related to long-lived assets and other non-cash costs, including accelerated depreciation and impairments upon abandonment or disposal of machinery and equipment.
A summary of the charges recognized in the consolidated statements of operations for the period from June 30, 2025 to September 29, 2025, the period from September 30, 2025 to June 28, 2026 and for the fiscal year ended June 29, 2025 resulting from these restructuring activities is shown below:
| | | | | | | | | | | |
| Successor | Predecessor |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | Period from June 30, 2025 to September 29, 2025 | Fiscal Year Ended June 29, 2025 |
Accelerated depreciation | $— | | $5.6 | | $33.6 | |
| Inventory write-down/scrap | 11.7 | | 2.5 | | — | |
Other closure-related costs | 14.5 | | 10.0 | | 63.5 | |
| Total cost of revenue, net | 26.2 | | 18.1 | | 97.1 | |
| | | |
| Impairments on abandoned assets | 1.8 | | 0.1 | | 170.2 | |
Severance(1) | — | | 0.1 | | 72.9 | |
Accelerated depreciation(2) | — | | — | | 11.4 | |
| Contract termination costs | 1.6 | | 2.3 | | 18.6 | |
Other closure-related costs | 2.9 | | 1.2 | | 32.0 | |
| Restructuring and other expenses | 6.3 | | 3.7 | | 305.1 | |
Total | $32.5 | | $21.8 | | $402.2 | |
(1 )Employee severance and benefit costs include the early exit program activity.(2) Includes net impact of change in salvage value and estimated useful life related to 150mm fab tooling and equipment.
A summary of the balance sheet activity during the period from June 30, 2025 to September 29, 2025 related to the 2025 Restructuring Plan is shown below: | | | | | | | | | | | | | | | | | |
| Predecessor |
| (in millions of U.S. Dollars) | As of June 29, 2025 | | Charges | Usage | September 29, 2025 |
Employee severance and benefit costs(1) | $25.2 | | | $0.1 | | ($11.9) | | $13.4 | |
Contract termination liability | 5.5 | | | 2.3 | | (2.0) | | 5.8 | |
Total | $30.7 | | | $2.4 | | ($13.9) | | $19.2 | |
| | | | | |
| | | | | |
(1)Employee severance and benefit costs includes the early exit program activity. A summary of the balance sheet activity during the period from September 30, 2025 to June 28, 2026 related to the 2025 Restructuring Plan is shown below: | | | | | | | | | | | | | | | | | |
| Successor |
| (in millions of U.S. Dollars) | As of September 30, 2025 | | Charges | Usage | June 28, 2026 |
Employee severance and benefit costs(1) | $13.4 | | | $— | | ($12.4) | | $1.0 | |
Contract termination liability | 5.8 | | | 1.6 | | (3.3) | | 4.1 | |
Total | $19.2 | | | $1.6 | | ($15.7) | | $5.1 | |
| | | | | |
| | | | | |
(1)Employee severance and benefit costs includes the early exit program activity. A summary of the balance sheet activity during fiscal 2025 related to the 2025 Restructuring Plan is shown below: | | | | | | | | | | | | | | | | | |
| Predecessor |
| (in millions of U.S. Dollars) | As of June 30, 2024 | | Charges | Usage | June 29, 2025 |
Employee severance and benefit costs(1) | $— | | | $72.9 | | ($47.7) | | $25.2 | |
Contract termination liability | — | | | 18.6 | | (13.1) | | 5.5 | |
Total | $— | | | $91.5 | | ($60.8) | | $30.7 | |
| | | | | |
| | | | | |
(1)Employee severance and benefit costs includes the early exit program activity.
The restructuring liability of $5.1 million at June 28, 2026, relating to severance payments and contract terminations, is recorded in the "accounts payable and accrued expenses" and "other current liabilities" and "other long-term liabilities" line items of the consolidated balance sheets, respectively.
2026 Restructuring Plans
During the second quarter of fiscal 2026, the Company implemented and substantially completed a headcount reduction (the "2026 Restructuring"), of approximately 8%, to better align with business needs as a result of the transition of Wolfspeed's internal chip manufacturing to 200mm and reduced demand for 150mm substrates. The severance and benefit costs related to this initiative were recorded in the second quarter of fiscal 2026 in accordance with the provisions of ASC 712-10, "Nonretirement Postemployment Benefits". No further charges are expected.
A summary of the charges recognized in the consolidated statements of operations through the period from September 30, 2025 to June 28, 2026 resulting from these restructuring activities is shown below:
| | | | | | | | | | | |
| Successor | | | |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | | | | | |
| Severance | 7.5 | | | | | | | |
| Restructuring and other expenses | $7.5 | | | | | | | |
A summary of the balance sheet activity related to these restructuring activities recognized in accounts payable and accrued expenses in the consolidated balance sheet as of June 28, 2026 follows: | | | | | | | | | | | | | | | | | |
| Successor |
| (in millions of U.S. Dollars) | As of September 30, 2025 | | Charges | Usage | June 28, 2026 |
| Employee severance and benefit costs | $— | | | $7.5 | | ($6.7) | | $0.8 | |
Total | $— | | | $7.5 | | ($6.7) | | $0.8 | |
| | | | | |
| | | | | |
During the fourth quarter of fiscal 2026, the Company approved a restructuring plan designed to further optimize its organizational structure with current business needs. The Company recorded severance and related benefit costs in accordance with the provisions of ASC 712-10, "Nonretirement Postemployment Benefits". This planned workforce reduction of approximately 6% of the employee population is expected to occur by the first half of fiscal 2027. The Company expects to incur approximately $4 million of total restructuring costs related to involuntary severance costs, with the remainder being incurred during the first half of fiscal 2027.
A summary of the charges recognized in the consolidated statements of operations through the fourth quarter of fiscal 2026 resulting from these restructuring activities is shown below:
| | | | | | | | | | | |
| Successor | | | |
| (in millions of U.S. Dollars) | Period from September 30, 2025 to June 28, 2026 | | | | | | |
| Severance | 3.0 | | | | | | | |
| Restructuring and other expenses | $3.0 | | | | | | | |
A summary of the balance sheet activity related to these restructuring activities recognized in accounts payable and accrued expenses in the consolidated balance sheet as of June 28, 2026 follows: | | | | | | | | | | | | | | | | | |
| Successor |
| (in millions of U.S. Dollars) | As of September 30, 2025 | | Charges | Usage | June 28, 2026 |
| Employee severance and benefit costs | $— | | | $3.0 | | $— | | $3.0 | |
Total | $— | | | $3.0 | | $— | | $3.0 | |
| | | | | |
| | | | | |